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ABSTRACT 
Wilms' tumour (WT), a renal tumour of early childhood, arises as a result of uncontrolled 
proliferation in the stem cells of the kidney due to an anomaly in their developmental pathway. A 
strong genetic element is known to be involved in its genesis, with more than one gene being 
implicated. The first of these, WT1, has recently been isolated and shown to be expressed in a specific 
pattern in both the developing human kidney and the tumour itself. The purpose of the work presented 
in this thesis was to examine the role that this gene plays in mouse embryogenesis, a system that lends 
itself to experimentation more readily than the human. Here, the expression of the mouse homologue 
of WT1 was examined in three complimentary systems; the developing mouse embryo, the kidney as it 
formed both in vivo and in vitro and finally, in a possible mouse model for WT. 
A comprehensive study of the expression pattern of WT1 during development was undertaken, 
using in situ mRNA hybridisation. Expression was first apparent in a small area of the lateral 
mesoderm in the 9 day embryo. Within 12 hours this had increased markedly, with both the lining of 
the whole coelomic cavity and the early urogenital ridge being labelled. As development proceeded, 
expression was initiated in a limited set of tissues which included the metanephros, the mesothelium, 
the gonads, the spleen, the developing body -wall musculature, the spinal cord and the brain. 
Expression was present in 15 day embryos but markedly reduced by 19 days with labelling being 
restricted to the kidney. 
The expression of WT1 in cultured kidney rudiments was then examined and found to be 
consistent with that observed in vivo. The gene was expressed at a low level in condensed 
mesenchyme, with a much higher level being detected in the developing renal corpuscle. Using the 
transfilter system of organ culture, it was shown that WT1 was expressed in the cap of condensed 
metanephric mesenchyme prior to induction and that this level increased after induction, a result 
confirmed using very early 11 day embryos. 
The mouse model of WT involved placing embryonic kidneys under the capsule of adult 
kidney or testis from 3 strains of mice, with the growths being recovered after a defined period. In 
contradiction of the published data, two distinct morphologies were observed, neither of which 
resembled classic WT. Both types of morphology were examined with WTI and antibodies to 
developmental markers and it was found that the degree of differentiation was considerably greater in 
the transplanted tissue than would be expected for WT. 
The results as a whole substantiate the importance of WT1 in tissue undergoing a mesenchyme- 
to- epithelial transition, 'particularly during nephrogenesis. The functional significance of WT1 
transcription in tissues outwith this group is less clear. Skeletal muscle is sometimes observed as a 
component of WT and it is intriguing that the gene is expressed transiently during a stage of muscle 
development. The data from the mouse points to a key role for WT1 in the initiation of the cascade of 
differentiation necessary for normal kidney development. The possible reasons for the failure of the 
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Renal malignancies in young children have been recorded since the early nineteenth 
century, but, as is often the case, Wilms' tumour (WT) derives its name from the author of a 
much later review of the disease (Wilms, 1899). Many of the early reports suggested an 
embryonic origin for the tumour, which is also called nephroblastoma, and it was soon 
recognised that a developmental anomaly lay behind its formation (Nicholson, 1931; Willis, 
1958). WT is now considered to arise from the stem cells of the kidney and often includes 
structures that represent the various stages of nephrogenesis. It is a model for investigating 
the proposed relationship between malignancy and abnormal differentiation and as such has 
recently been the subject of intensive research (reviewed by van Heyningen & Hastie, 1992). 
The work presented in this thesis examines the expression and possible role in 
mouse embryogenesis of the gene, WT1, that was isolated by positional cloning as a 
candidate WT predisposition gene, has been implicated in urogenital development and 
mutations in which have been associated with the tumour (for details see section 1.4). The 
need for such a study is two -fold: human embryonic material is both more difficult to obtain 
and less amenable to experimental manipulation than that of the mouse. Here, WT and the 
isolation and characterisation of WT1 is discussed, but to set the context in which the 
tumour forms and the gene is functional, we must first consider the development of the 
normal mammalian kidney at both the cellular and molecular level and follow this by a brief 
outline of the formation of the genital system. 
1.1 íMoG'maI dev&©pment of the kidney 
The nephron, which is the basic element of the excretory system of all vertebrates, 
has been found in the fossil record of the ostracoderms, the oldest known vertebrates 
(Torrey, 1965). Based on variations in the detailed structure of the nephrons and in their 
spatial assembly in living animals, the developing renal system can be divided into three 
distinct organs, the pronephros, the mesonephros and the metanephros. All three develop 
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from the intermediate mesenchyme that forms two identical blocks of mesodermal tissue 
running along the dorsal wall of the embryo. These are called the nephrogenic cords in the 
cervical and thoracic regions and the urogenital ridges in the coelomic cavity, where they 
widen. 
The paired pronephric ducts, later called the mesonephric or Wolffian ducts, extend 
caudally as development proceeds and are central to the formation of the excretory system. 
In addition to their role as a drainage channel, these ducts play an important part in the 
differentiation of both the mesonephros and the metanephros and this will be discussed 
later. Their origin and subsequent mode of elongation are two features of their formation 
that have been subjected to investigation (reviewed by Saxen, 1987). The ducts are derived 
from mesoderm that is distinct from the pronephric mesenchyme, although the most caudal 
sections may be composed of pronephric tubules that have fused at their distal end. The 
mechanism of extension differs between vertebrate orders, with cell rearrangement, in situ 
segregation and cell proliferation all being implicated (Poole & Steinberg, 1984). The factors 
guiding the ducts have also been studied and, in the axolotl embryo at least, the surrounding 
mesoderm provides a gradient of adhesion (Poole & Steinberg, 1982; Zackson & Steinberg, 
1987). 
Before going on to describe the formation of the metanephros, it will be helpful to 
examine briefly the first two renal systems, and Figure 1.1 demonstrates the spatial 
relationship between the three organs. 
1.1.1 The pronephros and mesonephros 
Studies of the pronephros have concentrated on the more primitive vertebrates, 
such as the bony fish and the amphibians, both of which have pronephroi that function in the 
embryo (reviewed by Saxen, 1987). Here, the pronephric tubules open directly into the 
coelomic cavity with 'external glomeruli' developing from the coelomic epithelium. In 
amniotes however, the rostral end of the nephrogenic cord remains rudimentary. Conclusive 
demonstration of a pronephros in the mouse has not been possible, but in man, the organ is 
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Figure 1.1 
An overall scheme of the development of the vertebrate kidney. P, pronephros; Nd, nephric duct; Nc, 
nephrogenic cord; G, gonad; Ms, mesonephros; Mt, metanephros; U, ureteric bud; Cl, cloaca (Sa'en, 
1987). 
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represented by several transient cell clusters within the intermediate mesoderm of the 
cranial region that are seen at approximately 22 days of gestation (Potter, 1972). 
The mammalian mesonephros is a temporary structure, but a degree of variation is 
observed among different species in both the relative size of the organ and in its maturity. In 
the late 9 day mouse embryo, the mesenchyme of the nephrogenic cord condenses, forming 
aggregates that develop a lumen (the mesonephric vesicle) and become S- shaped 
(mesonephric tubule), thus showing a similarity to those events in the metanephros which 
are considered in more depth in the following section. The sequence of tubule formation and 
subsequent degeneration runs caudally so that an elongated ovoid structure is formed. 
Although the nephric ducts make contact with the wall of the cloaca by day 10 of gestation, 
they do not drain into it until day 14 and this, together with the absence of well -differentiated 
mesonephric glomeruli, leads to the assumption that this organ is non -functional in the 
mouse (Kaufman, 1992). In man, where approximately 40 tubules form from day 25 
onwards (Potter, 1972), there is also no direct proof of functional maturity (Saxen, 1987). 
1.1.2 Overview of the formation of the metanephros 
The development of the metanephros, which starts early on day 11 of mouse 
gestation or day 35 for man, has been extensively reviewed (Potter, 1972; Saxen, 1987; 
Bard & Woolf, 1992; Ekblom, 1992). Nephrogenesis depends on a reciprocal inductive 
interaction between two tissues; the cells of the metanephric mesenchyme and the 
epithelium of the ureteric bud (Figure 1.2), which originated from the mesonephric duct. As 
a result of this interaction the bud elongates into a dense cap of mesenchymal cells and a 
complex cascade of events is initiated. If the kidney developed in a similar manner to other 
ducted organs such as the submandibular gland, the branches of the growing ureteric bud 
would give rise to the entire epithelial component. In the case of the metanephros, however, 
the parts of the nephron involved in filtration, secretion and reabsorption differentiate from 
the mesenchyme and it is only the collecting ducts, involved in excretion, that are derived 
from the ureteric bud. 
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Figure 1.2 Schematic presentation of the development of the nephron from induction to the 
formation of the glomerulus within the renal corpuscle (adapted from Ekblom, 1992). 
(a) The ureteric bud (U) grows into the metanephric mesenchyme (Mm) and a reciprocal 
inductive interaction takes place (arrows). 
(b) Induction leads to branching of the ureteric bud and further condensation of the 
mesenchyme, that forms a cap (C) around the tips of the bud. Note that there is evidence at 
this stage of vascularisation (arrow). 
(c) The cells of the condensate become organised into first a renal vesicle (not shown) and 
then a comma -shaped body. The blood vessel grows into the slit which has formed at the 
pole furthest from the ureteric bud (arrow). 
(d) The S- shaped body is formed by elongation of the comma -shaped body and by the 
formation of a second slit (arrow). The presumptive visceral (V) and parietal (P) epithelial 
layers of Bowman's capsule can be distinguished at this stage. 
(e) The S- shaped body elongates while the endothelial cells form a capillary bed or glomerlus 
(G) within Bowman's capsule. 
(f) The mature nephron. 
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(c) Comma -shape 
(b) Condensation 
(d) S-shape 
(e) Tubule elongation 
Figure 12 
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(f) Podocyte folding 
As the bud grows it bifurcates, with the mesenchyme adjacent to it condensing 
further and segregating into clumps (Figure 1.2). These in turn become organised into 
pretubular aggregates, or renal vesicles, the cells of which develop a polarity and elongate 
but continue to have a uniform ultrastructure. A comma -shaped body develops from the 
renal vesicle by the formation of a slit that divides the future tubular epithelium from that 
associated with the glomerulus (the presumptive Bowman's capsule) and into which 
endothelial cells migrate. It is at this stage that the renal anlage fuses to the collecting 
system (Jokelainen, 1963). Further growth and the formation of a second slit leads to the 
production of the S- shaped body. Diversification in the ultrastructure of the cells, that was 
first apparent during the comma -shaped stage, becomes more marked and will be 
considered in a later section. The loop of Henle and the proximal and distal convoluted 
tubules are created by further growth. 
Within the developing kidney, a temporal and spatial gradient of differentiation exists 
so that all stages of nephrogenesis can be seen in a longitudinal section. In a 15 day mouse 
embryonic kidney, for example, there is a progression from the undifferentiated stem cells of 
the outer cortex, through the early condensates and developing nephrons, to more mature 
nephrons at the border of the cortex and medulla. In man, the terminal nephrons are formed 
between the 32nd and 36th week of gestation and further growth is by cell proliferation within 
the existing tubules (Osathanondh & Potter, 1963), whereas in many other species 
nephrogenesis continues after birth (Saxen, 1987). Another feature that needs to be 
considered is that, in contrast to the mouse kidney which is unilobar and has a smooth outer 
surface, the human metanephros has a more complex structure as it is composed of many 
lobes. The multilobed structure is particularly striking in human material that has been 
sectioned where the stem cells of the outer cortex can in fact lie deep within the organ. 
1.1.3 In vitro development of the kidney 
The need for a technique that allowed the controlled manipulation of the 
metanephros as it formed led to the development of an in vitro organ culture system for the 
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mouse kidney (Grobstein, 1953a,b; 1956) and this has subsequently been modified and 
improved (Saxen, 1987). Much of the work that will be described in the following sections 
resulted from experiments carried out using either whole -organ or transfilter culture and 
these will be considered in turn. 
For whole -organ culture, metanephric rudiments from mouse embryos of 11.5 days 
of gestation are dissected out and placed on porous filters that are maintained at the air - 
liquid interface of a dish containing an appropriate medium. The surface tension ensures 
that the rudiments remain covered by a thin layer of medium and if good differentiation is 
required, these are then cultured for about 6 days. Development will proceed to an 
advanced stage with branching of the collecting system and the mesenchyme -to- epithelium 
transition occurring to produce mature tubular structures (Bard & Ross, 1991). 
In the transfilter system, the metanephric rudiments from 11 day embryos (where 
induction has not yet occurred) are isolated and the mesenchyme and ureteric bud 
components separated either enzymatically or mechanically. The ureteric bud, which does 
not work efficiently across a filter, is replaced by a heterologous inducer such as the 
embryonic spinal cord. The tissues are placed opposite each other, on the upper and lower 
surface of a porous filter, immobilised with agar, and cultured in conditions similar to the 
whole -organ for up to 5 days. The degree of morphological differentiation seen in this 
system has been compared to that in vivo and found to be remarkably similar, including the 
development of proximal tubules with a well- defined brush border, distal tubules and renal 
corpuscle -like bodies with podocytes, but no endothelial cells (Ekblom et al., 1980a; 1981a; 
Bernstein et al., 1981). This system is particularly useful for experiments involving cell or 
tissue interaction and has provided unequivocal proof that the epithelial cells of the nephron 
are derived from the mesenchyme. 
1.1.4 Induction of the metanephric mesenchyme 
The study of the mechanisms underlying the differentiation of the mesenchyme into 
epithelium has been facilitated by the ability of the kidney to develop in vitro. The transfilter 
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technique has been used to investigate the initial interaction and has demonstrated that, if 
the mesenchyme is isolated from the ureteric bud and cultured alone, it fails to grow very 
well or to differentiate (Grobstein, 1955). A variety of tissues in addition to the natural 
source have been found to induce (or trigger) the metanephric mesenchyme into forming 
tubules (Grobstein, 1955; Unsworth & Grobstein, 1970; Saxen, 1987). In contrast, no other 
mesenchyme has been shown to produce nephrons (Saxen, 1970) and it has been 
concluded that the metanephric mesenchyme has a pre- determined kidney bias, with the 
induction being permissive rather than directive (Saxen, 1977). These two categories have 
been defined as follows: for directive induction, the embryonic cell has more than one 
developmental option with the choice being affected by extracellular factors; in permissive 
induction, however, the cell is already committed to a particular developmental pathway, but 
requires a stimulus to express this new phenotype (Saxen, 1977). The inductive stimulus 
need not be long and exposure of the mesenchyme to the inducer for 24 h has been shown 
to be sufficient to lead to the formation of the epithelial cells of Bowman's capsule and the 
proximal tubule (Saxen & Lehtonen, 1978). Using electron microscopy, it has been 
demonstrated that, during transfilter experiments, cytoplasmic processes from the cultured 
tissues penetrate the pores of the filter and become closely apposed. This has led to the 
suggestion that cellular interaction, rather than long range diffusion of a signal substance, is 
responsible for induction (Wartiovaara et aL, 1974). 
The transfilter experiments established that embryonic spinal cord was a more 
efficient inducer than the ureteric bud and this led to the idea that nerves may be involved in 
the process. Nerve cells have been found in undifferentiated kidneys running along the 
ureter, with processes going out into the mesenchyme (Sariola et al., 1988a) and antibodies 
that prevent their binding to mesenchymal cells disrupt differentiation (Sariola et aL, 1989). 
The most powerful evidence to support this hypothesis, however, is the demonstration that 
antisense oligonucleotides that bind to the neural- growth -factor (NGF) receptor mRNA 
suppress receptor synthesis and also prevent nephrogenesis (Sariola et al., 1991). 
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The changes that occur as the induced mesenchyme undergoes epithelialisation 
have been studied extensively using immunohistochemistry. Before induction, the cells are 
not in direct contact and are surrounded by a matrix that includes fibronectin (Ekblom, 1981) 
and the interstitial collagens I and Ill (Ekblom et al., 1981b). In addition, the neural cell 
adhesion molecules (N -CAM), a family of related glycoproteins, are expressed on the cell 
surface (Klein et aL, 1988). As the induced mesenchyme forms aggregates, fibronectin and 
collagens I and Ill disappear rapidly, so allowing closer cell contact (Ekblom, 1981; Ekblom 
et al., 1981b), whereas N -CAM remains on the epithelial cells until polarisation, as assayed 
by the formation of a lumen, is evident (Klein et aL, 1988). The cell surface proteoglycan, 
syndecan, which is a receptor for interstitial matrix material and thus acts as an adhesion 
molecule between cells, has been detected first in the mesenchyme surrounding the 
unbranched ureteric bud, then, as this bifurcates, in the entire metanephric mesenchyme; it 
therefore seems to be an early response to induction (Vainio et al., 1989). Proteins specific 
for desmosomes, which are intercellular junctions associated with epithelial sheets, have 
been found in the initial aggregate and may well play a role in strengthening the contact 
between cells of the early kidney tubule (Garrod & Fleming, 1990). 
The formation of a basement membrane, or basal lamina, is a characteristic feature 
of epithelial cells and electron microscopy studies have shown that in the kidney it starts to 
appear around the renal vesicle shortly after this structure aggregates and is complete by 
the time the S- shaped body forms, even extending into the slits (Jokelainen, 1963). The 
main constituents of the basal lamina are laminin, heparin sulphate proteoglycan and 
collagen IV and these have been detected in the mesenchymal aggregates as a punctate 
pattern, becoming confined to the outer edge of the renal vesicle and giving rise to a sharp 
continuous band around the more mature tubules ( Ekblom, 1981; Ekblom et al., 1980b; 
1981b; Bonadio et al., 1984). 12 h after the completion of induction, the cell adhesion 
molecule, uvomorulin, is produced (Vestweber et al., 1985) and is co- expressed with N -CAM 
for a short period (Klein et al., 1988). In the cytoskeleton, the intermediate filament vimentin, 
11 
uniformly present in the uninduced mesenchyme, is replaced in the forming tubules by 
cytokeratin, a marker for epithelial cells (Lehtonen et al., 1985). 
Tenascin, a mesenchymal matrix protein (Chiquet -Ehrismann et aL, 1986) has been 
observed around the condensates and S- shaped bodies, so supporting the hypothesis that 
this molecule is involved in epithelial- mesenchymal interactions (Aufderheide et al., 1987). A 
similar role has been indicated for the cell surface glycolipid, GD3, because monoclonal 
antibodies that react with GD3 prevent branching of the collecting system and the 
mesenchyme -to- epithelium transition (Sariola et aL, 1988b) 
It is an intriguing observation that the aggregates form from mesenchyme that is 
already condensed. In vitro studies have shown that rudiments grown on a substrate to 
which they adhere weakly form fewer nephrons than those grown on more sticky substances 
and these results suggest that there is a mechanical aspect to this condensation rather than 
a prepattern (Bard, 1990a). 
We now have some insight into the neural basis of induction and the subsequent 
changes in the molecular phenotype of the differentiating mesenchyme are well 
documented, but two important questions remain to be fully addressed. The first of these is 
whether all of the metanephric mesenchyme is induced at once, while the second again 
concerns the mesenchyme which has two developmental options; either to become 
interstitial mesenchyme or to be transformed into epithelium, and it is not clear if these are 
both derived from induced tissue. These problems are fundamental to the understanding of 
the formation of WT and, as we shall see later, have yet to be answered satisfactorily. 
1.1.5 Formation of the collecting system 
The interaction between the mesenchyme and the duct is reciprocal, with the bud 
failing to branch in organ culture if the mesenchyme is removed (Grobstein, 1955), and 
seems to be specific as no heterologous mesenchyme has been reported to support 
branching (Saxen, 1970). Little is known about the mechanisms underlying branching in the 
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kidney but an analogous organ, the submandibular salivary gland, has been studied 
extensively (reviewed by Bernfield et al., 1984; Bard, 1990b). In this system, it has been 
proposed that the mesenchyme degrades and then remodels the epithelial basal lamina and 
the branching pattern seems to result from the interaction between the epithelium and the 
mesenchyme. Until we have a better understanding of the process in the kidney, the 
salivary gland is the best model, but the differences in the formation of the two organs limit 
the conclusions that can be drawn. 
The branching pattern of the ureteric bud in the human embryo has, however, been 
described in detail and the process divided into 4 periods (Osathanondh & Potter, 1963) with 
a similar course of events occurring in the rat (Neiss, 1982). The first of these periods is 
marked by the dichotomous branching of the ureteric bud at the widened tips or ampullae. 
There are two types of dichotomous branching; symmetric and asymmetric, with the latter 
occurring when the two branches differ in their subsequent development. In the second 
stage, the collecting system has stopped branching but the ampullae have retained their 
ability to induce renal vesicle formation. This leads to more than one nephron fusing to each 
tip, with the more mature ones shifting position and thus forming an arcade (Figure 1.3). 
During the third period the collecting duct grows past the attachment point of the arcade and 
although it does not branch again it does induce a terminal set of nephrons (Figure 1.3). 
The last period is characterised by the termination of induction and the cessation of nephron 
formation due to the disappearance of the ampullae at the end of the previous stage. 
Studies of human development have also shown that the early branches of the 
ureteric bud dilate soon after the formation of the first glomeruli to form the renal pelvis, the 
calyses and the papillae (Potter, 1972). A consequence of this is that the collecting ducts 
that drain into the papillary ducts are in fact up to 11 generations removed from the initial 






Figure 1.3. The arrangement of the human nephrons at birth, illustrating periods 2 and 3 of 
the development of the collecting system. Four deeper nephrons constitute an arcade, 
formed during period 2, while the six cortical nephrons are directly connected to the 
collecting duct, a characteristic feature of period 3 (Osathanondh & Potter, 1963). 
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1.1.6 The renal corpuscle and angiogenesis 
The normal development of the kidney depends on a fourth cellular component, the 
endothelial cells of the vascular system. These cells form a capillary bed, or glomerulus, 
within Bowman's capsule and this is collectively termed the renal corpuscle. The origin of 
the endothelial cells has been the cause of much controversy and it was Potter (1965) who 
first put forward the suggestion, now widely held, that these cells migrate into the kidney 
from an external source. Indirect evidence for this hypothesis was provided by the 
demonstration of avascular renal corpuscles in the transfilter system (Bernstein et al., 1981; 
Ekblom, 1981), but direct proof awaited experiments using the avian chorioallantoic 
membrane (CAM). Mouse metanephric rudiments were grown on the quail CAM and, based 
on the distinctive nuclear structure of the quail cells, it was concluded that the capillaries 
were derived from the host tissue and thus had an external origin (Ekblom et aL, 1982). A 
further study, in which separated uninduced and experimentally induced metanephric 
rudiments were grafted onto the quail CAM showed that the stimulation of endothelial cell 
the the ureteric bud and the (Sariola et 
al., 1983). The guiding signal for the migration of the capillaries is unknown, but the 
embryonic kidney has been shown to produce an angiogenic factor (Risau & Ekblom, 1986). 
The section of the nephrogenic epithelium that will give rise to Bowman's capsule 
can, as previously mentioned, be identified at the stage of the comma -shaped body. Shortly 
afterwards (during the S- shaped phase) a further diversification occurs so that two cell types 
can be distinguished; the future visceral epithelium (or podocytes) and the parietal epithelium 
(see Figure 1.2). Morphologically, the cells of the visceral layer are more columnar than 
those of the parietal layer and in addition have a different lectin- binding capacity (Ekblom et 
aL, 1981 a) and express ZO -1, a protein first detected in tight junctions, at a higher level than 
other cells of the nephron (Schnabel et aL, 1990). In the mature renal corpuscle, the 
podocytes are closely apposed to the endothelial cells and have a stellate appearance, with 
radiating primary processes that give rise to secondary ones called pedicels or foot 
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processes. These interdigitate with those of other podocytes to create a system of 
intercellular clefts called slit pores that are involved in filtration. 
The podocytes are separated from the endothelial cells by a basal lamina, the 
glomerular basement membrane (GBM), which is the main filtration barrier of the kidney. 
Experiments using CAM grafts have demonstrated that the GBM is derived from both cell 
types and thus has a dual cellular origin (Sariola et aL, 1984). The source of another 
component of the renal corpuscle, the mesangial cells, has also been investigated. These 
cells, whose function is not clear, were not observed in the avascular renal corpuscles 
formed in vitro (Bernstein et aL, 1981) and CAM graft experiments have shown that these 
cells are derived from the host tissue suggesting they are either vascular derivatives or 
migrate into the kidney rudiment with the endothelial cells (Sariola et aL, 1984). 
1.2 Development of the genital system 
From a functional point of view, the urinary and genital systems are very different, 
but they do have a close developmental and anatomical connection, being formed from a 
common mesodermal ridge, the intermediate mesoderm. It is therefore of no surprise that 
WT is often associated with genital abnormalities and a brief description of normal 
development follows (reviewed by Moore, 1982; Kaufman, 1992). 
Although the sex of the mammalian embryo is predestined chromosomally at the 
time of fertilisation, the morphological distinction is only possible from day 12.5 of gestation 
in the mouse or from 7 weeks in the case of the human embryo. Prior to this, the gonads, 
which will go on to differentiate into either the ovaries or the testes, are said to be 
'indifferent'. They first appear on day 10 (5th week in the human) as a thickening of the 
coelomic epithelium with an underlying condensation of the mesenchyme on the lateral side 
of each mesonephros and are termed the genital or gonadal ridges. The proliferating 
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coelomic epithelium goes on to invade the subjacent mesenchyme, forming the irregularly 
shaped primary sex cords. 
In male embryos, the primary sex cords condense to form the seminiferous cords 
and these give the developing testis its characteristic striped appearance. These cords, 
which subsequently lose contact with the surface epithelium, develop a lumen, while the 
mesenchyme between them gives rise to the interstitial cells of Leydig. The seminiferous 
tubules are made up of two cell types: the Sertoli cells derived from the surface epithelium 
and which predominate in the embryonic organ and the spermatogonia which differentiate 
from the primordial germ cells. As it enlarges, the testis becomes separated from the 
regressing mesonephros and becomes suspended from its own mesentery, the mesorchium. 
In the female embryo, the primary sex cords degenerate, but the surface epithelium 
continues to proliferate, giving rise to the secondary or cortical cords. These remain close to 
the surface and incorporate the primordial germ cells. The cortical cords break down in turn 
to form isolated cell clusters or follicular cells which surround the germ cells (oogonia). 
During the initial 'indifferent' period, both sexes have two pairs of genital ducts: the 
mesonephric (Wolffian) and paramesonephric (Mullerian) ducts. The formation of the 
mesonephric duct has already been described (see section 1.1), with the paramesonephric 
duct being formed from an invagination of the coelomic epithelium on the lateral surface of 
the urogenital ridge, possibly induced by the presence of the subjacent mesonephric duct. 
In the male embryo, the testes produce anti -Mullerian hormone (AMH) that causes the 
paramesonephric ducts to regress and stimulates the mesonephric ducts to form the 
epididymis, ductus deferens and the ejaculatory ducts of the adult. In the female embryo, 
the mesonephric ducts regress in the absence of the stimulus provided by the testes and the 
rostral end of the paramesonephric duct opens into the coelomic cavity with a funnel -like 
structure, which will become the oviduct in the adult. As the duct runs caudally in the human 
embryo, it comes into close contact with the corresponding duct of the opposite side and 
these later fuse to give rise to the uterus and upper vagina. In most other mammalian 
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species, including rodents, however, the two paramesonephric ducts remain as separate 
entities along most of their course. 
1.3 Wilms° tumour 
Having set out the developmental context in which WT stands, we will now consider 
the clinical background of the malignancy (reviewed by Greenwood & Holland, 1984; 
Pritchard -Jones & Hastie, 1990) before going on to discuss the genetic aspects. WT is one 
of the most common solid tumours occurring in infants, affecting on average 1 in 10,000 live 
births and seems to have a relatively uniform distribution throughout the world, although 
there is evidence of variation between certain ethnic groups. The tumour is very rare in the 
new -born, with the median age at diagnosis being between 3 and 4 years and 90% of cases 
presenting before the age of 7. Most cases of WT are sporadic and unilateral, but between 
5% and 10% are bilateral and a further 1% show familial transmission, where it is inherited 
as an autosomal dominant trait with variable penetrance (Matsunaga, 1981). When the age 
of onset for these groups was separated, the unilateral cases were found to be significantly 
older than those presenting with bilateral tumours (Breslow et al., 1988). 
Although the tumour has often grown to a large size before diagnosis, it is generally 
still confined to the kidney with local extension being more frequent than distant metastases. 
Where such distant metastic spread of the disease does occur, it is usually to the lungs by 
way of the bloodstream. Advances in medical treatment mean that the majority of cases can 
now be cured, but successful treatment is dependant to a degree on the histological profile 
of the tumour. 
1.3.1 Histopathology of Wilms' tumour 
The classic triphasic morphology, which has been described for many of the 
tumours, involves three cell types that are all derivatives of the kidney stem cell, namely the 
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blastemal, stroma! and epithelial cells. There is, however, a wide variation in the histological 
appearance and tumours may be composed predominantly of only one or two cell types. 
Details of the classification of the tumour will not be considered here (for description see 
Kidd, 1984), but it should be pointed out that two subtypes have been designated as being 
distinct from WT; clear -cell sarcoma and malignant rhabdoid tumour, both of which have a 
high mortality rate (Beckwith, 1983). In addition, the association of anaplasia (cells with 
large hyperchromatic nuclei and abnormal mitotic figures) with WT has been recognised as a 
marker of an unfavourable prognosis (Beckwith & Palmer, 1978). 
The origin of the three cellular components found in triphasic tumours has been 
examined in the context of normal nephrogenesis and based on a review of ultrastructural 
and immunohistochemical studies (Mierau et al., 1987). The blastemal cells have been 
proposed to represent the condensed mesenchyme of the kidney during the formation of the 
initial renal aggregates. The histogenesis of the stroma! component has not yet been 
resolved, although there are indications that it corresponds to mesenchyme that has yet to 
undergo aggregation, rather than to the connective mesenchyme of the mature kidney. 
Alternatively, it may be the product of the malignant blastema (Brown et al., 1989). The 
primitive epithelial tubules, that are often observed, are thought to represent an early stage 
in nephrogenesis, such as the normally transient renal vesicle, and only in very rare cases 
are structures indicative of late nephrogenesis (i.e. the proximal tubule) seen. In some 
examples, 'glomeruloid- bodies' form and these seem to be attempts to differentiate into the 
renal corpuscle. There is also evidence that a proportion of the epithelial tubules are 
derivatives of the collecting duct system and these may originate from the adjacent normal 
kidney. In addition, components such as striated muscle, cartilage, bone, adipose tissue 
and neural tissue are sometimes seen and these are usually associated with areas of 
stroma! cells. These heterologous elements are not normal derivatives of the kidney stem 
cell and are considered to be produced as a result of inappropriate differentiation. 
Lesions that may be the precursor of WT, have been found in up to 44% of kidneys 
removed due to unilateral WT and in nearly 100% of those associated with bilateral cases of 
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the disease (Bove & McAdams, 1976; Beckwith et al., 1990). These lesions, or nephrogenic 
rests (NR), are foci of embryonal cells that are thought to have retained their pluripotency 
and have been divided into intralobar (ILNR) and perilobar (PLNR) categories (Beckwith et 
al., 1990). The former occur throughout the body of the kidney and are mainly stromal, with 
small areas of blastemal cells and the occasional epithelial component, suggesting an early 
developmental aberration. PLNR are well -defined islands of predominately blastemal cells 
at the periphery of the lobes of the kidney and are thought to represent a disturbance during 
late nephrogenesis. Multiple or diffuse NR can occur and this condition has been termed 
nephroblastomatosis. The histological appearance of the tumours associated with the two 
classes of lesions is also different: ILNR are found in conjunction with predominately stromal 
tumours and frequently contain heterologous elements, whereas PLNR seem to be linked to 
tumours with a later onset that often show evidence of epithelial differentiation. PLNR are, 
however, also found in 1% of all infant post- mortems (Bennington & Beckwith, 1975), which 
suggests that, if they are a premalignant lesion, the majority do not progress to WT. 
1.3.2 Congenital abnormalities 
Although most cases of WT are unilateral and sporadic, several congenital 
abnormalities are known to be associated with the tumour (Miller et aL, 1964; Pendergrass, 
1976) and these have proved invaluable in understanding the disease. There is a significant 
increase in the number of malformations involving the urogenital system, with those of the 
urinary tract including duplex and horse -shoe kidneys, double ureters and renal agenesis 
(Breslow & Beckwith, 1982). Genital abnormalities seem to be more common in males and 
range from cryptorchidism (undescended testis) and hypospadias (abnormal penile 
development) (Breslow & Beckwith, 1982), to the more severe phenotype of gonadal 
dysgenesis (Rajfer, 1981). 
It was the surprisingly high proportion of aniridia patients (absence of the iris), who 
subsequently developed WT (Miller et aL, 1964), that first suggested a locus for a gene. 
Approximately one third of sporadic aniridia cases later develop WT (Fraumeni & Glass, 
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1968) and 1 in 100 of WT cases are born with aniridia (again mainly sporadic)(Breslow & 
Beckwith, 1982) as compared to an incidence in the general population of 1:64,000 (Shaw et 
aL, 1960). Many of these patients have genitourinary abnormalities and are mentally 
retarded and this collective phenotype is known as the WAGR syndrome (Wilms, Aniridia, 
Genitourinary abnormalities and mental Retardation). Constitutional deletions spanning part 
of the short arm of one homologue of chromosome 11 (the distal half of band 11p1 3) were 
cytogenetically observed in a number of patients with the WAGR syndrome (Riccardi et aL, 
1978; Franke et aL, 1979). The WT gene from this locus has recently been isolated by 
positional cloning (Call et aL, 1990; Gessler et aL, 1990) and will be discussed in detail in a 
later section. 
Three further syndromes are associated with WT and these are; Beckwith - 
Wiedemann (BWS), Denys -Drash and Perlman's syndrome. BWS is characterised by fetal 
gigantism, that is often asymmetric giving rise to hemihypertrophy, and also by abnormal 
closure of the abdominal wall (Wiedemann, 1964; Beckwith, 1969). A high proportion (7 %) 
of patients with BWS develop abdominal tumours, the most common of which is WT 
comprising more than half of such tumours (Wiedemann, 1983). The Denys -Drash 
syndrome encompasses pseudohermaphroditism, intrinsic renal parenchymal disease 
(nephrotic syndrome) and WT (Denys et aL, 1967; Drash et al., 1970) and is characterised 
by a specific glomerular lesion, with shrunken glomerular tufts surrounded by hypertrophied 
epithelial cells (Habib et aL, 1985). Perlman's syndrome is the phenotype comprised of 
nephroblastomatosis, fetal gigantism and cryptorchidism in males (Perlman et aL, 1973). 
There is a high incidence of stillbirth and neonatal death in this syndrome, but those that 
survive subsequently develop WT. 
1.3.3 Genetics of Wilms' tumour 
Malignancies of early childhood have become the focus of research into the genetic 
changes associated with cancer because they are thought to need fewer mutational steps 
than those with a later onset (reviewed by Haber & Housman, 1991). This idea is based on 
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the 'two -hit' hypothesis, a model that had originally been proposed for retinoblastoma (RB), a 
childhood eye tumour (Knudson, 1971), but was subsequently modified for WT (Knudson & 
Strong, 1972). Statistical analysis was carried out on a large collection of tumours with the 
age of onset and the number of malignant growths per individual being compared, so that 
the number of rate limiting events could be estimated. The 'two -hit' hypothesis predicts that 
in hereditary cases, the first mutation is present at the prezygotic (germinal) stage and 
therefore exists in all cells. Only one additional mutation is then needed in a cell of the 
target organ to give rise to a tumour. Non -hereditary tumours, on the other hand, are 
postulated to be caused by two postzygotic (somatic) mutations occurring in the same cell. 
As the probability is very small that two somatic mutations would occur in more than one 
cell, this model predicts that multiple and bilateral tumours are hereditary cases. The earlier 
onset of bilateral tumours also reflects the idea that the first mutation is carried in the 
germline. 
Although Knudson's model only went so far as to estimate the number of rate 
limiting steps, it has since become synonymous with the idea that mutations disrupting both 
alleles of a single gene are necessary and sufficient for the formation of the tumour. The 
suggestion that nephroblastoma is due to a loss of gene function has led to it being classed 
with the so- called 'anti -oncogenes' or 'tumour suppressor' genes (Klein, 1987: Weissman et 
al., 1987; Marshall, 1991). This term is, however, misleading because it implies that the 
gene is only involved in preventing uncontrolled cell proliferation and fails to acknowledge 
any role for it in normal development. 
RB has been shown to conform to the 'two -hit' hypothesis with the isolation of RB1, 
the gene at 13q14, that is inactivated in cases of this tumour (Friend et aL, 1986; Fung et al., 
1987; Lee et aL, 1987). For WT, karyotype analysis of WAGR patients had demonstrated 
loss of genetic material corresponding to the first -hit predicted by Knudson. Polymorphic 
DNA probes were then used to show that in sporadic tumours there was loss of 
heterozygosity for the short arm of chromosome 11 (Fearon et aL, 1 984; Koufos et aL, 1984; 
Orkin et aL, 1984; Reeve et al., 1984), that was restricted to 11p13 in a couple of cases 
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(Wadey et aL, 1990). In the case of WT, however, the 'two -hit' hypothesis is not in itself 
sufficient to explain the complex nature of the malignancy because there seems to be at 
least two more genes, in addition to the one at 11p13, implicated in the development of the 
tumour. 
A locus on the short arm of chromosome 11 that is closer to the telomere was 
indicated by loss of heterozygosity in the majority of cases of the tumour examined for 
markers within 11p15 that did not involve 11p13 (Mannens et aL, 1988; Reeve et aL, 1989). 
Additional evidence stems from the fact that in several individuals with sporadic BWS a 
constitutional duplication of 11p15 has been reported (Waziri et al., 1983; Turleau et aL, 
1984a) and rare cases of familial BWS have been shown to be tightly linked to the 11p15 
locus (Koufos et aL, 1989; Ping et al., 1989). The demonstration of trisomy at 11p15, with 
most cases involving duplication of the paternal allele, indicates that a different mechanism 
from chromosome deletion may be involved. Furthermore, several cases have now been 
described where instead of duplication of 11p15 there was no maternally inherited copy, with 
both alleles being contributed by the father (Henry et aL, 1991), suggesting that differential 
imprinting of the paternal allele together with gene dosage may be the mechanism involved 
in BWS. It is of interest in this context that the gene for the insulin -like growth factor II (IGF- 
I/) is located at 11p15 (Bell et al., 1985) and that this gene is known to be imprinted in the 
mouse, with only the paternal allele being expressed during normal development (DeChiara 
et aL, 1990; 1991). To add to the genetic complexity, familial cases of WT have been shown 
by linkage analysis to map outside chromosome 11 (Grundy et al., 1988; Huff et aL, 1988; 
Schwartz et aL, 1991), indicating that a third gene locus may be involved. 
The question arises as to whether tumours resulting from genetic loss at 11p13 
differ from those involving either 11p15 or the familial locus. Although there is little data on 
this at present, it has been shown that the NR associated with BWS differ from those seen in 
conjunction with WAGR (Beckwith et al., 1990). ILNR have been found to be strongly 
associated with aniridia and Denys -Drash syndrome, while PLNR have been linked with 
hemihypertrophy and BWS. 
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1.4 Isolation of WT1, the gene at 11p13 
The region containing the 11p13 WT predisposition gene was defined using somatic 
cell hybrids containing fragments of human chromosome 11 in a Chinese hamster cell 
background (Kao et al., 1976). It was found to lie between the erythrocyte catalase gene 
(CAT) and the ß subunit of the follicle -stimulating hormone (FSHB) (Junien et aL, 1980; van 
Heyningen et aL, 1985; Glaser et aL, 1986). That the aniridia (AN2) and WT genes, 
although genetically close, are actually separate genes was indicated by a patient with a 
constitutional deletion of 11p13 who had nephroblastoma and cryptorchidism, but did not 
have aniridia (Turleau et al., 1984b) and this was subsequently confirmed (Davis et aL, 
1988a; Gessler et aL, 1989). The order of the genes was established to be centromere- 
CAT-WT-AN2- FSHB -telomere. A large number of DNA markers for this interval were 
generated (Porteous et aL, 1987; Bickmore et aL, 1988; Davis et aL, 1988b; Gessler et aL, 
1989) and pulsed -field gel electrophoresis (PFGE) was used to generate long -range physical 
maps of the region (Compton et aL, 1988; Gessler & Bruns, 1989; Davis et aL, 1990; Rose 
et aL, 1990). A single sporadic tumour was described that contained two unequal deletions 
(Lewis et aL, 1988) and this narrowed the interval to 350 kb (Compton et aL, 1990; Rose et 
aL, 1990). The homologous loss in this tumour was also the first direct evidence that the 
gene at this locus is a 'tumour suppressor'. The region of genitourinary abnormalities maps 
to the same 350 kb stretch and could either be one gene with pleiotropic effects or two 
separate but closely linked genes (van Heyningen et aL, 1990). 
The candidate WT gene was isolated independently by two groups using different 
experimental approaches. Call et aL (1990) isolated several genomic clones (they used a 
cosmid library prepared from a somatic cell hybrid containing the short arm of chromosome 
11) that mapped to the WAGR region. They went on to identify one clone that showed 
strong cross -species hybridisation to hamster and mouse genomic DNA and to RNA from 
baboon kidney and spleen. This genomic probe was then used to screen human cDNA 
libraries derived from adult kidney, an embryonic kidney cell line and a pre -B cell line. 
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Several overlapping cDNA clones were identified with the longest one, WT33 (2.3 kb), being 
derived from the pre -B cell line library. 
PFGE analysis of the 11p13 region had previously revealed several CpG islands 
(Compton et aL, 1988; Bickmore et aL, 1989; Gessler & Bruns, 1989), which are structures 
frequently associated with the 5' ends of expressed sequences (Bird, 1986). Starting from 
one of these CpG islands, the second group (Gessler et al., 1990) isolated 4 neighbouring 
islands using a rare -cutting restriction -enzyme 'jumping' library. The genomic regions 
flanking these islands were examined and two showed cross -species conservation. The 
RNA transcript from one of these genomic clones was found to be expressed specifically in 
the embryonic kidney and was used to isolate a 3 kb cDNA (LK15) from a human fetal 
kidney cDNA library. LK15 corresponds to the gene cloned by Call and co- workers and that 
is now known as WT1 (Haber et al., 1990). 
1.4.1 Structure of WT1 
The WT1 gene contains 10 exons that span 50 kb of DNA and encodes a mRNA 
transcript of 3 kb (Call et aL, 1990; Gessler et aL, 1990; Haber et al., 1991). Sequence 
analysis of the cDNA that was cloned, predicted that the polypeptide product has two 
functional domains: four carboxy -terminal zinc fingers and a proline -glutamine rich amino - 
terminal region (Call et al., 1990; Gessler et al., 1990; Figure 1.4). This, together with the 
nuclear location of the protein (Pelletier et al., 1991a), suggests that WT1 is a transcription 
factor and thus has a role in the transcriptional control of other genes. In order to 
understand the possible role of WT1 we must first discuss transcription factors and then go 
on to look at zinc -finger containing genes. 
Transcription factors are sequence- specific polypeptides that have been grouped 
into families on the basis of their DNA -binding motifs and show a high level of conservation 
between species. In many cases a second region, the transactivation domain, has been 
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Figure 1.4. Diagrammatic representation of the WT1 gene product. WT1 encodes a protein 
that contains four zinc fingers at the carboxy- terminus and a proline -glutamine rich region at 
the amino -terminus. Two alternatively spliced segments are found in the WT1 transcript, 
resulting in a combination of four distinct mRNA species. Splice I encodes 17 amino acids, 
while splice Il encodes 3 amino acids that disrupt the linker region between zinc fingers 3 
and 4 (Haber & Buckler, 1992). 
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& Tjian, 1989). The first regulatory factors to be identified, the prokaryotic DNA -binding 
proteins, such as the lambda repressor, have a common helix- turn -helix motif that has been 
shown to interact with the DNA (Pabo & Sauer, 1984). This general structure is shared by 
many of the homeotic genes of Drosophila and these contain a nucleotide sequence called 
the homeobox that encodes the homeodomain, a 60 amino acid region with DNA -binding 
specificity (reviewed by Gehring et aL, 1990). The homeobox is conserved in vertebrates 
and has been found in a large family, the Hox genes. Mutation analysis of Drosophila 
embryos has shown that the homeobox containing genes are important in the determination 
of the anterior -posterior axis and in the formation and identity of the segment. The zinc 
finger, the POU domain and the leucine zipper are further examples of DNA -binding motifs 
that have been identified so far. 
Zinc -finger proteins can be divided into two classes on the basis of the number and 
position of the cysteine (C) and histidine (H) residues which co- ordinate zinc chelation 
(reviewed by Evans & Hollenberg, 1988). The C2H2 class, to which WT1 belongs, is 
exemplified by the Xenopus laevis transcription factor TFIIIA, the first zinc- finger protein to 
be described (Miller et aL, 1985). This family contains pairs of C and H separated by a loop 
of twelve amino acids, with at least two tandem repeats linked by between 7 and 8 amino 
acids. The second class, the Cx proteins, have a variable number of C residues and include 
the yeast GAL4 gene (Pan & Coleman, 1990) and the steroid receptor family (Hard et al., 
1990). The sequence of WT1 has been compared to that of other zinc -finger genes and 
found to be most homologous to a class of mammalian early growth response genes, the 
EGR (human) and Krox (mouse) families, that are expressed during the GO to G1 transition 
in cultured cells (Chavrier et al., 1988; Joseph et al., 1988; Sukhatme et aL, 1988). The 
interaction between the zinc fingers of EGR -1 and DNA has been studied in detail using X- 
ray crystallography (Pavletich & Pabo, 1991) and this has allowed the functional significance 
of WT1 mutations to be examined (see section 1.4.2). Other examples of zinc -finger 
encoding genes include general transcription factors such as Spi (Gidoni et aL, 1984) and 
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the Drosophila segmentation genes Hunchback (Tautz et aL, 1987) and Kruppel (Rosenberg 
et al., 1986). 
The genomic structure of WT1 has also been examined in some detail (Haber et al., 
1990; 1991). Each of the zinc fingers is encoded by a distinct exon and is separated from 
the next finger by a short intron. Another feature of the WT1 gene is that it produces 4 
distinct mRNAs reflecting the presence or absence of 2 alternatively spliced exons (Figure 
1.4). Splice I is a separate exon that codes for 17 amino acids, including 5 serine and 1 
threonine residues (sites of potential protein phosphorylation), and is inserted between the 
proline- glutamine rich region and the zinc -finger domain. The second splice is an alternative 
5' splice junction that results in the insertion of 3 amino acids (1 serine and 1 threonine) 
between fingers 3 and 4 and which affects the DNA -binding specificity of the protein 
(Bickmore et al., 1992). Using RNase protection it has been shown that the most common 
transcript in human and mouse kidneys is that including both extra splices, whereas the least 
abundant is that with neither splice (Haber et aL, 1991). The relative distribution of these 
four transcripts has also been examined and found to be conserved between normal fetal 
kidney and cases of WT with intact transcripts. In the developing mouse kidney, the ratio of 
the 4 splice variants remained constant with time and was also similar in the genital tissue. 
1.4.2 Genetics of WT1 
Although substantial evidence had been accumulated to support a role for WT1 in 
the formation of WT, direct proof awaited the demonstration in the tumour of mutations 
involving only this gene. In several cases, deletions have been reported that include WT1 
but that extend beyond the locus and could involve other genes (Lewis et al., 1988; Gessler 
et al., 1990). Using Southern blot analysis, gross rearrangements of the gene have been 
detected in approximately 8% of tumours, and homozygous deletion within WT1 
demonstrated (Cowell et al., 1991; Tadokoro et al., 1992). In accordance with Knudson's 
'two -hit' hypothesis, a bilateral case has been described with an intragenic germline deletion 
that had become homozygous in both tumours (Huff et aL, 1991). Most mutations are not 
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detectable at this level, however, and the reverse transcriptase- polymerase chain reaction 
(PCR) method has been employed to amplify and analyse mRNA from a collection of 
tumours. Using this technique, a WAGR patient has been found with a constitutional 
deletion of 11p13 and an intragenic deletion of the remaining WT1 allele (Brown et al., 
1992). It is of interest that several genes flanking WT1 have been shown to be expressed in 
fetal kidney (Bonetta et al., 1990), but there is no genetic evidence to support a role for 
these in WT. 
In addition to homozygous inactivation of WT1, there may be another mechanism 
that contributes to the formation of the tumour. A case of a sporadic tumour has been 
described where equal amounts of the wild -type and mutant WT1 transcripts are expressed 
(Haber et al., 1990). This mutation results in a protein that lacks one of the zinc fingers, and 
which if functional, could suppress the activity of the normal protein. In a separate study, 
chemical mismatch cleavage analysis has been employed to examine the zinc- finger region 
of WT1 for genomic point mutations (Little et al., 1992). Two exonic single base changes 
were detected: the first involved a nonsense mutation leading to an arginine residue 
becoming a stop codon in zinc finger 3, while the second was a missense mutation in one 
allele resulting in a change of an arginine to a cysteine in zinc finger 2. By comparison to the 
structure of EGR -1, the mutation in the second example seems to be critical for DNA - 
binding. Furthermore, by analogy to hunchback, a Drosophila transcription factor (Tautz et 
al., 1987), the resulting cysteine may confer a different binding specificity for WT1 and this 
might well disrupt or compete with the binding activity of the normal allele. Such 'dominant - 
negatives' have been found for p53, a tumour suppressor gene implicated in many human 
malignancies (Levine et al., 1991), and indicate that a single genetic hit at the WT1 locus 
may be sufficient for tumourigenesis in certain cases. Another, equally probable mechanism 
is that inactivation of one WT1 allele could be interacting with alterations at a second locus. 
There is evidence that both the 11p13 and 11p15 loci can contribute to the formation of a 
single tumour (Henry et al., 1989). 
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The isolation of WT1 has allowed the involvement of the 11p13 locus in genital 
abnormalities to be investigated. Two children presenting with WT, hypospadias and 
cryptorchidism were shown to have constitutional null mutations in WT1 and these cases 
raise the possibility that reduced dosage of the gene can lead to malformations of the 
genitalia (Pelletier et aL, 1991b). One of these cases also indicated that WT1 may have a 
role in familial WT. In two independent studies, patients with Denys -Drash syndrome, that 
characteristically have more severe genital abnormalities than those with WAGR, were 
examined (Pelletier et al., 1991c; Bruening et al., 1992). Germline point mutations in the 
zinc -finger domain of one allele of WT1 were found in all cases, except one that affected 
alternative splicing, and suggests that altering the DNA- binding specificity of the protein may 
lead to a greater effect on genital development than its loss. 
1.4.3 The pattern of WT1 expression 
The expression of WT1 has been examined in both the tumour and human 
embryonic tissue by northern blotting and in situ mRNA hybridisation. It has been shown by 
northern analysis that WT1 detects a transcript of approximately 3 kb in baboon kidney and 
spleen (Call et aL, 1990). In another study human fetal tissues were examined and a 3.2 kb 
transcript was observed in the kidney, spleen, testis and ovary with an additional 2.7 kb 
transcript in the testis (Pritchard -Jones et al., 1990). Very weak expression was also found in 
the brain, but none was observed in the heart, skin, adrenals, stomach, liver, eye or muscle. 
The pattern of WT1 expression in an 18 week human fetal kidney was examined using in 
situ mRNA hybridisation (Pritchard -Jones et aL, 1990). There was a low level of labelling in 
the condensed mesenchymal cells, which increased in the renal vesicle and was then 
restricted to the maturing renal corpuscle. It was strongest within the podocyte cells of 
Bowman's capsule with no expression being observed in the rest of the nephron. A similar 
but much weaker pattern was seen in the normal kidney adjacent to a WT from a 10 month 
old male. To investigate a possible role in early development, human embryos (6 -7 weeks) 
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were examined and the metanephric mesenchyme and the glomerular epithelium of the 
mesonephros were found to be positive. In addition, the germinal epithelium and the sex 
cords of the gonads, together with the mesothelial lining of the coelomic cavity and its 
contents, expressed WT1. 
Tumours have also been examined using northern analysis and, although the 3.2 kb 
transcript was detected in every case, there was a 500 -fold variation in the level of WT1 
expression, with tumours that were predominately blastemal or epithelial having the highest 
level and stromal ones the lowest (Pritchard -Jones et aL, 1990; Huang et aL, 1990; Miwa et 
aL, 1992a). In situ mRNA hybridisation was used to show that WT1 expression was 
dependent on the histology of an individual tumour (Pritchard -Jones & Fleming, 1991). The 
blastemal areas were found to express the gene, whereas the stromal elements did not label 
above the background level. The highest level of positive signal was associated with 
epithelial differentiation and in particular with the glomeruloid- bodies. The majority of tubular 
structures also labelled, but, in the few cases that did not express WT1, 
immunohistochemistry demonstrated that these either represented elements that had 
developed to a stage beyond the S- shaped body or were derived from the ureteric bud. 
WT1 transcripts are therefore found in the malignant equivalent of cells that express the 
gene during normal nephrogenesis. 
As WT1 was isolated from an haematopoietic cell line, it is of interest that northern 
analysis has demonstrated expression of the gene in cell lines from human leukaemias 
(Pritchard -Jones & Hastie, 1990; Miwa et aL, 1992b). WT1 was not, however, transcribed in 
all cases of the disease: those of immature phenotype such as acute lymphoblastic 
leukaemia and acute mylogenous leukaemia expressed the gene, while those of a more 
mature type, including chronic lymphocytic leukaemia, did not (Miwa et aL, 1992b). This 
pattern, together with expression in the spleen, suggests that WT1 may be involved in the 
early stages of haematological cell differentiation. 
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1.4.4 Interaction of WT1 with other genes 
The expression pattern of the WT1 gene is consistent with its having a role in 
normal development, and there has been some discussion of the possible target sequences 
for this transcription factor. VVT1 could function by repressing genes involved in cell 
proliferation or alternatively by activating those required for differentiation. Possible targets 
that fit into the first category include the proto -oncogene N -myc and the mitogen IGF -11, both 
of which are expressed in the metanephric mesenchyme at a level that decreases as 
epithelial differentiation takes place (Mugrauer et al., 1988; Mugrauer & Ekblom, 1991; Brice 
et al., 1989). These two genes are also expressed at a high level in WT: N -myc is 
transcribed in the tumour at a much higher level than in the embryonic kidney (Nisen et al., 
1986), while that of 1GF -11 is comparable to embryonic kidney (Reeve et aL, 1985; Scott et 
aL, 1985). IGF -ll is of particular interest because of the association of this gene with the 
11p15 locus (for a review of the IGF -ll gene, see Schofield, 1991). In a recent study, WT1 
was co- transfected into cultured cells with the promoter region of the two IGF -II transcripts 
expressed in human fetal kidney and the basal level of IGF -11 was found to be significantly 
repressed (Drummond et aL, 1991; Drummond et al., 1992). Furthermore, examination of 
the IGF -II promoter sequence revealed several potential high affinity binding sites for WT1 
and gel shift assays have confirmed this. As to the second category, any of the genes that 
are expressed as the stem cells of the metanephric mesenchyme condense and undergo 
epithelialisation can be considered as possible targets for WT1 (for details see section 
1.1.4). 
Many developmentally important genes are expressed in a specific way in the kidney 
as it forms and any of these could be regulated by WT1. Several of the Hox genes are 
expressed during the development of the mesonephros and metanephros (reviewed by 
Holland & Hogan, 1988). In situ hybridisation studies have shown that while several of the 
genes from this family are expressed uniformly in the metanephric mesenchyme and the 
tubular epithelium (Dolle & Duboule, 1989; Gailliot et aL, 1989), others are transcribed at a 
higher level in the forming nephron (Dolle & Duboule, 1989) or restricted to the collecting 
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system (Kress et al., 1990). HNF1 and vHNF1 are two genes that contain a homeodomain 
with an extra 21 amino acids. HNF1 was first identified as a transcriptional regulator of 
several liver specific genes and may form heterodimers with vHNF1 (Chouard et al., 1990; 
Rey- Campos et al., 1991). In the rat embryonic kidney vHNF1 is expressed in metanephric 
mesenchyme undergoing the initial aggregation after induction and in conjunction with HNF1 
in later stages of nephrogenesis (Lazzaro et al., 1992). 
The murine Pax genes are a family which have a common protein binding domain, 
the paired -box, which was first described in the Drosophila segmentation genes paired and 
gooseberry (Bopp et al., 1986) and is conserved in man (Burri et al., 1989). In most 
members of this family, a second domain, the paired homeodomain that has diverged from 
the homeobox, is also observed. The Pax genes are expressed in a tissue specific manner 
during development with in situ mRNA hybridisation data showing that Pax -2 and Pax -8 
which show extensive homology are expressed during the development of both the 
mesonephros and the metanephros. Pax -2 is expressed in the ureter, the condensed 
mesenchyme and epithelial derivatives of the metanephros and is down -regulated as the 
nephron continues to differentiate (Dressler et aL, 1990), while the expression of Pax -8 is 
similar but does not include the ureter (Plachov et al., 1990). The localisation of Pax -2 
expression in WT has been examined using polyclonal antibodies and shown to be restricted 
to areas of epithelial differentiation (Dressler & Douglass, 1992). 
In contrast to these surmised targets, a direct analysis has been carried out on the 
binding of the WT1 protein to DNA. Using a construct containing the zinc -finger region of 
WT1, it has been shown that this domain identifies binding sites that are similar to those 
recognised by EGR -1 (Rauscher et al., 1990). In the same study, the alternative splice of 3 
amino acids inserted between the 3rd and 4th zinc finger reduced binding affinity, as did a 
mutation that had previously be described in a case of WT where the 3rd zinc finger was 
deleted (Haber et al., 1990). The glutamine-proline rich region has been observed to 
repress transcription when bound to the EGR -1 site (Madden et aL, 1991). The most 
prevalent mRNA species is, however, the one that contains the extra 3 amino acids (Haber 
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et aL, 1991) and this form has recently been shown to encode a protein that can also bind 
with a different specificity to DNA (Bickmore et al., 1992). This observation has led to the 
suggestion that the two alternative forms recognise distinct binding sites and may have 
different functional roles. Furthermore, the germline point mutation described in a case of 
Denys -Drash syndrome that affected alternative splicing supports the idea that the WT1 
isoforms may play different roles during the development of the urogenital system (Bruening 
et al., 1992). 
1.5 The murine homologue of WT1 
Initial experiments using the human WT1 gene to probe northern blots had indicated 
that the gene was expressed in the mouse fetal kidney and this led to it being used to screen 
a 17 day mouse embryonic kidney cDNA library (Buckler et aL, 1991). Five clones were 
isolated, but none of these included the part corresponding to the 5' end of the characterised 
human cDNAs, so an adult mouse testis library was subsequently screened to obtain longer 
clones. The complete nucleotide sequence of the murine WTI cDNA (3,089 bp) is given in 
the appendix. If the mouse and human polypeptides are compared, a high degree of 
homology is seen ( >96 %) with the differences occurring mainly outside the zinc -finger 
region, although these are not conservative changes (see appendix for details). The 
expression pattern of this gene is not considered here, but will be described in chapter 3. 
The occurrence of WT in species other than man is very rare and almost unheard of 
in the mouse (Hard, 1984a,ó). It should also be born in mind that the Dickie's Small -eye 
(Seydey) mouse mutant carries a deletion of part of chromosome 2, the murine homologue 
of the WAGR region of human chromosome 11, that includes both the AN2 and WT1 loci 
(Glaser et aL, 1990). The homozygotes die before implantation, while the heterozygotes are 
born with eye abnormalities that vary in severity and a reduction in body size of about 10 %, 
but have no evidence of kidney abnormalities or of WT (Theiler et aL, 1978). In addition to 
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this spontaneous variant, two further allelic mutations have been described; SeyH (Lyon & 
Searle, 1979) and Sey (Hogan et al., 1986). It has been suggested that SeyDey and SeyH 
are caused by large deletions, whereas Sey, that has a much less extreme phenotype, is an 
intragenic deletion or point mutation. That a mouse carrying a deletion of one WT1 allele 
never develops WT could reflect differences in the degree of genetic complexity between the 
two species or alternatively those involved in nephrogenesis. 
The mouse, nevertheless, is an excellent system in which to study WT1 and offers 
several distinct advantages; its greater developmental and genetic accessibility, the 
production of transgenic animals and the in vitro kidney culture system. The cloning of the 
murine homologue of the WT1 gene should allow such advantages to be exploited. 
1.6 Thesis outline 
In this introduction, the current understanding of both the genetic and developmental 
basis of WT has been laid out so that the implications of the results obtained here, 
describing the expression pattern of the mouse WT1 gene during development, can be 
considered. The next chapter, details the materials and methods used during the course of 
this work. The results are presented in three separate chapters, each with its own local 
introduction and short discussion. The first of these examines the expression of WT1 in the 
developing mouse embryo using in situ mRNA hybridisation, the second details its 
expression in the metanephric kidney both in vivo and in vitro with the final chapter 
investigating a model that had been proposed to give tumours, that have a morphology 
similar to WT, in the mouse. Finally, in the last chapter, an overview of the thesis will 
discuss the significance of this data and suggest work that will be relevant in the further 
understanding of the role of WT1. 
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CHAPTER 2 
MATERIALS AND METHODS 
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In the course of this thesis a wide variety of techniques were used and these are 
outlined in this chapter. A list of the companies that supplied the chemicals, antibodies and 
enzymes is given at the end in Section 2.8. 
2.1 Collection of embryonic material 
A breeding colony of Swiss mice, an albino outbred strain, was maintained by the 
animal house at the Western General Hospital. Timed matings were set up, so that the 
morning on which the vaginal plug was noted was designated as day 0.5 post coitum (p.c.). 
Pregnant females were killed by cervical dislocation and their uterine horns removed under 
sterile conditions. After isolation, the embryos were staged accurately using the 
morphological criteria given by Theiler (1989), and processed as described below in Section 
2.2. The 15 and 19 day p.c. embryos had their heads removed, with the older stage being 
skinned prior to processing. Metanephric kidneys were also dissected out in Dulbecco's 
phosphate buffered saline (PBS) with disposable hypodermic needles, using a Wild - 
Heerbrugg M7A dissecting microscope. 
2.2 Processing of tissue samples 
The method chosen for fixing and embedding a particular tissue depended on the 
subsequent procedures that would be applied and a detailed explanation of these 
considerations is given in Bancroft and Stevens (1990). 
2.2.1 Paraffin wax embedding 
For in situ mRNA hybridisation, tissue was fixed overnight at 4 °C using freshly 
prepared 4% paraformaldehyde (PFA) in PBS and for immunohistochemistry, 10% neutral 
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buffered formalin was employed (50 ml formaldehyde, 9.3 g NaH2PO4, 2.1 g NaOH and 450 
ml H2O). After fixation, the specimen was washed in PBS for 30 min, transferred to 30% 
EtOH for 30 min and then into 70% EtOH for 30 min. The tissue could be left at this stage 
indefinitely, as long as the EtOH was changed occasionally, but was usually left overnight. 
After a third change of 70% EtOH, dehydration was completed using 100% EtOH (3 steps of 
1 h). The specimen was cleared with xylene (2 changes of approximately 15 min), placed in 
a 60 °C oven for 10 min and then transferred to molten paraffin wax (melting point 56 °C). 
After three 1 h changes, the tissue was finally embedded in fresh wax using copper 
embedding irons as moulds or in glass dishes for embryos less than 10 days old. 
The tissue was sectioned at a thickness of 7 gm using a Reichert-Jung 2030 
microtome. For in situ mRNA hybridisation, 3 strings were mounted in parallel under sterile 
conditions on slides coated with 3- aminopropyltriethoxy -silane (TESPA) using a floating -out 
bath and dried overnight at 60 °C. Strings for immunohistochemistry were cut into individual 
sections, mounted on welled slides (C.A. Hendley, Ltd.) using a hot plate and dried overnight 
at 50 °C. Routine histological analysis of section after 
staining with haematoxylin and eosin (H & E, see Bancroft and Stevens, 1990 for details). 
The slides for in situ mRNA hybridisation were stored with desiccant until required. 
2.2.2 Araldite embedding for electron microscopy 
The tissue was cut into small pieces (approximately 1 mm3) and fixed overnight at 
room temperature in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.3, 468 
mOsm) containing 0.1 M sucrose. After fixation, the specimen was rinsed in the buffer (2 
times 10 min) and post -fixed in buffer containing 1% osmium tetroxide for 1 h. It was then 
rinsed and dehydrated through the following series of graded alcohols: 10, 30, 50, 70, 95 
and 100% EtOH. The tissue was cleared using propylene oxide (2 times 10 min), before 
being transferred to a foil dish containing a thin layer of araldite CY212 and left overnight at 
room temperature to allow the resin to infiltrate. The dish was then heated to 60 °C for 35 
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min and the specimen transferred to fresh araldite, that was then polymerised by heating at 
60 °C for 3 days. 
All of the cutting was carried out by the EM department, with a LKB5 ultramicrotome 
using glass knives. Thin sections (70 nm) were floated out onto distilled H2O, picked up 
using 3 mm copper grids (TAAB) and stained in saturated uranyl acetate in 50% EtOH at 
room temp for 30 min. After 10 s washes in 50 %, 30% and 10% EtOH followed by distilled 
H2O, the sections were stained in 1% Reynold's lead citrate for 15 min. Finally the sections 
were rinsed in dH2O and allowed to air dry. A Philips 300 transmission electron microscope 
(TEM) was used to view and photograph the sections. 
2.3 Preparation of DNA 
The production of the riboprobe described in section 2.4.1 requires a clean DNA 
sample as a template and this was obtained using the techniques detailed below (general 
reference; Sambrook et aL, 1989). 
2.3.1 Bacterial strain and plasmid vector used 
The WT1 insert (kindly provided by Prof. David Housman; sequence given in the 
appendix) had been cloned into the Eco RI sites of pbluescriptKS+ by Wendy Bickmore. 
This 3 kb vector was derived from the pUC 19 plasmid (Messing, 1983) with the addition of 
T3 and T7 promoter sequences that flank the polylinker, thus enabling the production of both 
sense and anti -sense mRNA transcripts. The advantages of this vector include; the high 
copy number, the ampicillin resistance gene and that the artificial polylinker has been 
inserted into the ß- galactosidase gene (lac -Z) as a test for recombinant plasmids. The 
plasmid was then transformed into the XL -1 Blue bacterial strain and given the clone name 
pkS /2. 
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2.3.2 Isolation of plasmid DNA 
To isolate plasmid DNA from bacterial culture, a protocol based on the alkaline lysis 
method of Birnboim and Doly (1979) was employed. A single colony was used to inoculate 
500 ml of terrific broth [13.3 g bacto- tryptone, 26.6 g bacto -yeast extract and 4.4 ml glycerol 
per I with 1/10 volumes of 1 M phosphate salts (164.32 g K2HPO4, 23.1 g KH2PO4) added 
prior to use] containing ampicillin, that was then grown up overnight on a shaker at 37 0C. 
The cells were harvested by spinning at 8,000 rpm for 10 min, the supernatant poured off 
and the pellet resuspended in GTE [50 mM glucose, 25 mM Tris -HCI, pH 8.0, 10 mM 
ethylenediaminetetraacetic acid (EDTA)] to give a final volume of 18 ml. A further 2 ml of 
GTE containing 10 mg /ml of lysosyme was added and left for 10 min at room temperature or 
until the solution became viscous. To denature the chromosomal DNA, 40 ml of freshly 
prepared 0.2 M NaOH, 1% sodium dodecyl sulphate (SDS) was added and the solution kept 
on ice for 5 min. To precipitate the bacterial debris, 20 ml of cold 5 M potassium acetate (pH 
4.8) was then added and after 15 min on ice the solution was spun at 15,000 rpm (15 min). 
The supernatant was separated by filtering through muslin and the plasmid DNA precipitated 
by the addition of 0.6 volumes of isopropanol. After 1 h at room temperature it was spun at 
8,000 rpm for 15 min. The supernatant was discarded, the pellet rinsed with 70% EtOH and 
allowed to air dry before being resuspended in 4 mis of TE (10 mM Tris, 1 mM EDTA, pH 
8.0). 
The volume was measured accurately and designated as X, with 0.1 ml /X ml of 10 
mg /ml EtBr and X g of CsCI being added. This was then put into ultracentrifuge tubes, 
balanced to within 0.1 g, sealed with a tube sealer and spun overnight at 100,000 rpm in a 
Beckman TL -100 ultracentrifuge. Taking care not to disturb the gradient, the lower of the 2 
bands observed was removed using a pastette and put into fresh tubes. These were topped 
up with the EtBr /CsCI solution and respun. The EtBr was completely removed using water 
saturated butan -1 -ol and the DNA precipitated by the addition of EtOH (placed at -20 °C for 
30 min and then centrifuged to pellet the DNA) before being redissolved in TE. The final 
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concentration was determined by reading the optical density using a spectrophotometer 
(Cecil CE594). 
2.3.3 Digestion of DNA 
In order to transcribe RNA, the template DNA had first to be linearised using the 
appropriate restriction enzyme. An enzyme was chosen that cleaved at a site in the 
polylinker sequence downstream of the insert with respect of the RNA polymerase promoter, 
but did not cut within the sequence. In the case of pkS /2, Barn HI was used in accordance 
with the manufactures instructions for the T3 promoter and Hind Ill for T7. After 
linearisation, the plasmid DNA was purified by phenol /chloroform extraction and isolated 
using EtOH precipitation [1/10 volumes of 3 M NaOAc and 3 volumes of cold EtOH ( -20 °C 
for 30 min)]. 
2.3.4 Agarose gel electrophoresis of DNA fragments 
Mini gels were routinely used to check that enzymatic digestion was complete and 
that the plasmid was properly linearised (a single sharp band). In order to prevent 
overheating of the mini -gel equipment 0.5 x TBE buffer (10 x TBE: 1 M Tris -HCI, 0.8 M 
Boric Acid, 20 mM EDTA, pH 8.3) was used to prepare 1% agarose gels. Stop mix (0.2 M 
EDTA, pH 8.1, 15% ficoll and Orange G) was added to the DNA and this migrates ahead of 
the fragments, thus acting as a visible migration front. The gels were run at 75 volts for 
approximately 30 min, stained with EtBr and viewed under UV light, before being 
photographed. Lambda DNA digested with Hind Ill was used as a size marker. 
2.4 In situ mRNA hybridisation 
The expression pattern of a gene can be visualised using the technique of in situ 
mRNA hybridisation on sections of tissue. The protocol outlined below was developed by 
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Duncan Davidson and Liz Graham (Davidson et al., 1988) from the method of Wilkinson et 
a/. (1987a, b). 
2.4.1 Preparation of riboprobe 
Single- stranded sense and anti -sense RNA probes were prepared, that incorporated 
35S -UTP, using T7 and T3 polymerase respectively. The transcription reaction was carried 
out at 37 °C for 50 min with fresh polymerase being added after 25 min. A concentration of 
50 mM dithiothreitol (DU) was maintained at all times to prevent oxidation of the radiolabel. 
To estimate the incorporation of radiolabel, a 1 µl aliquot of the reaction mix was added to 19 
µl of TE and divided between two glass fibre filters (Whatman GF /A filters). One was 
airdried, while the other was washed twice with cold TCA and once with EtOH. After drying, 
the filters were placed in pots containing 10 ml of Aquasol and the specific activity estimated 
in a scintillation counter (Packhard 1500) standardised for 35S emissions. The DNA 
template was removed by DNase I digestion (37 °C for 10 min) and the reaction stopped 
using 100 mM EDTA. The volume was increased with TE (pH 7.4) so that the RNA could be 
extracted using phenol /chloroform. The probe was EtOH precipitated at -20 °C overnight to 
remove any unincorporated nucleotides before being pelleted and washed twice with 80% 
EtOH and once with 100% EtOH. The pellet was dried in a vacuum and redissolved in water 
containing 0.1% Diethyl pyrocarbonate (DEPC). As cells are less accessible to transcripts of 
more than 150 bp, alkaline digestion (80 mM NaHCO3, 120 mM Na2CO3, pH 10.2, at 60 °C) 
was used to generate random fragments of this length. The time required to produce 
transcripts of approximately 150 bp was calculated using the following equation, with 60 min 
being an absolute maximum; 
t(min)= lo _0.1 where lo = insert size in kb 
0.011 xlo 
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The probe was recovered by EtOH precipitation (minimum of 3 h at -20 °C), spun, washed 
and dried. The pellet was redissolved in TE (pH 7.4) and the final specific activity estimated 
as described previously. At this stage the probe was stored at -70 °C until required. 
2.4.2 Treatment of slides prior to hybridisation 
The slides were dewaxed in two 10 minute changes of xylene and then rinsed in 
100% EtOH to remove the xylene (2 steps of 2 min). A series of graded alcohols was used 
to rehydrate the sections (90, 70, 50 and 30% EtOH) which were then washed in 0.85% 
NaCI and PBS for 5 min at a time. The tissue was fixed by being immersed in 4% PFA for 
20 min. After a further two 5 minute washes in PBS, the slides were treated with Protinase 
K (20 µg /ml in 50 mM Tris, 5 mM EDTA, pH 7.2) that digests the surface of the tissue, thus 
improving the access of the probe to the cellular mRNA. The time used was reduced from 
the standard 7.5 min to 3 min for delicate samples such as the kidney cultures. The slides 
were then rinsed in PBS for 5 min and fixed in 4% PFA for 5 min, before being treated with 
acetic anhydride (2.5 ml per 1000m1 of 0.1 M Triethanolamine, pH 8.0). This neutralises any 
basic charges on the sections that would bind the probe non -specifically. The slides were 
rinsed in PBS and 0.85% NaCI before being dehydrated through the graded alcohols. The 
slides were allowed to air dry and stored in a desiccator before use, which was usually within 
24 h, but could be up to 4 months. 
2.4.3 Hybridisation 
The probe was diluted in hybridisation mix [50% formamide, 10% dextran sulphate, 
1 x Denhardt's solution (50 x solution: 5 g ficoll, 5 g polyvinylpyrrolidone, 5 g BSA), 20 mM 
Tris -HCI (pH 8.0), 0.3 M NaCI, 5 mM EDTA, 10 mM NaH2PO4, 0.5 mg /ml yeast RNA and 
50 mM DTT added just prior to use] to give an estimated 1.2 x 105 dpm /µl. The diluted 
probe was denatured by heating it for 2 min at 80 °C before cooling rapidly on ice. 
A 10 µl aliquot of probe was placed on each string of sections, with sense probe 
being routinely placed on the middle string and anti -sense on the outer ones. Siliconised 
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coverslips were placed on top of each string to prevent the sections from drying out. The 
slides were placed in a slide box containing a cloth soaked in 50% formamide, 5 x sodium 
saline citrate (20 x SSC: 175.3 g NaCI, 88.2 g tri -sodium citrate) and this was then sealed 
and submerged in a waterbath at 55 °C for 16 -18 h. 
2.4.4 Post -hybridisation washes 
The slides were removed from the box and put into 5 x SSC, 10 mM DTT at 55 °C 
for between 15 to 30 min, or until all the coverslips were removed, before being transferred 
to an high stringency wash of 50% formamide, 2 x SSC, 0.1 M DTT at 68 °C for 20 min. The 
sections were treated with RNaseA to remove any non -specifically bound probe and the 
slides had to first be washed with NTE (0.5 M NaCI, 10 mM Tris, 5 mM EDTA, pH 7.5) in 
order to remove any traces of formamide. Thus, after three 10 min NTE washes at 37 °C, 
the slides were incubated with 40 mg /ml RNase A in NTE for 30 min. After a further 15 min 
wash in NTE, the slides were returned to a high stringency wash. The slides were then 
washed in 2 x SSC (3 steps of 10 min) and similarly in 0.1 x SSC. They were finally 
dehydrated through graded alcohols, which each contained 0.3 M ammonium acetate, and 
air dried in a dust -free environment. 
2.4.5 Autoradiography of slides 
The slides were coated under safelight (S 902) in Ilford K5 gel emulsion that had 
been warmed to 40 °C and then diluted 1:1 with distilled water. They were left to dry in a 
light tight box overnight and then placed with in a sealed box with desiccant at 4 °C for 
between 2 -4 weeks. 
2.4.6 Developing the slides 
Under safelight the slides were developed for 4 min using D19, rinsed for 10 
seconds in distilled water and then fixed for a further 4 min in a 1:3 solution of kodaf ix in 
distilled water. After a further two 10 minute washes in water, the slides were stained in 1% 
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Methyl Green and air dried. They were mounted in DPX and examined and photographed 
using a camera mounted on either a Zeiss Universal microscope or a Wild M400 dissection 
photomicroscope. 
2.4.7 Production of digitised images 
The inherent problems associated with the photography of the data from in situ 
mRNA hybridisation experiments led to the development of a computer -aided technique that 
superimposes the bright and dark field images. This was used in conjunction with 
conventional photography in the production of the figures in Chapters 3 and 4. 
A detailed description of the technique is given in Monaghan et al. (1991), but a brief 
summary is given here. The image was projected onto a monitor using a video camera 
mounted on the microscope. A software package was used to grab (digitise) the image 
which involved converting the image into a format that the computer could read and then 
display on the computer screen. This was repeated for both the bright and dark field images 
which were merged and thresholded to give a true signal using a shellscript program written 
under the Unix operating system. The image could then be photographed directly from the 
screen. All the digitising was carried by Liz Graham. 
2.5 Culture of kidney rudiments 
The whole -organ culture material used during this project was kindly supplied by 
Jonathan Bard and the transfilter tissue by Prof. Lauri Saxen. The embedding and 
sectioning was carried out by Allyson Ross. 
Metanephric kidney rudiments were dissected from 11 -11.5 day embryos with 
hypodermic needles and trimmed of surplus non -metanephric mesenchyme in serum -free 
Dulbecco's modification of Eagle's medium (DM EM) medium (11 day rudiments have a 
simple ureteric bud extending into the metanephric mesenchyme which is uninduced; by 
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11.5 day, this bud has bifurcated and the mesenchyme has been induced in the sense that, 
when isolated, it will differentiate in the absence of further inducing agent). The rudiments 
were picked up in a drawn -out Pasteur pipette and transferred to sterile Millipore discs (pore 
size 0.45 µm, diameter -2 mm) or small squares of Nuclepore filter (pore size 1.0 µm) on a 
trowell -type, stainless steel screen (some of whose holes had been enlarged). The screen 
had already been placed in a 3.5 cm petri dish to which had been added sufficient medium 
to ensure that the rudiments were held in place by surface tension at the air- medium 
interface. 
The rudiments were cultured in DMEM to which was added sodium bicarbonate (1.5 
gip, glutamine (0.3 g/l) and 10% foetal calf serum. This medium is not standard as it has 
one third the amount of usual bicarbonate: DMEM is normally used to culture rapidly growing 
cells which make acid; the amount of kidney tissue is so small that little acid is produced and 
normal DMEM becomes very alkaline. The rudiments were cultured for up to 6 days at 
37 °C in 7% CO2 with the medium being changed after 3 days. Additional experiments were 
carried out with media that contained LIF (leukaemia inhibitory factor) or cytochalasin B for 6 
days. In the case of LIF, Esgro was added to the media (8000 U /ml and 4000 U /ml were 
used). For the experiments involving cytochalasin B, 0.2 µg /m1 was added. 
For the transfilter cultures, mesenchymes were separated from their ureters with fine 
needles after the kidney rudiments had been incubated with trypsin (1 %) and pancreatin 
(0.5 %) in PBS at 0 °C for 90 s and allowed to recover for 10 min at room temperature. 
Meanwhile, neural tube was dissected from the 11 day embryos and cut into small ( -1 mm) 
pieces. To prepare the culture, the squares of Nuclepore filter were placed over the holes in 
a trowell grid in a 3.5 cm petri dish containing medium and fragments of neural tube placed 
on them. These were then immobilised with a tiny drop of molten agar in PBS which was 
allowed to solidify at 4 °C. After about 5 min, the filter was turned over and 2 or 3 
mesenchymes placed on the filter over the neural tube and these too were immobilised with 
agar. After the second agar drops had solidified, the dishes were incubated routinely for 1 -4 
days. 
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The cultured tissue was fixed in 4% PFA, embedded in wax, sectioned at 5 p.m and 
mounted on TESPA coated slides as described previously (Bard and Ross, 1991). 
2.6 Production of pseudo Wilms' tumours 
The data presented in Chapter 5 was obtained using the method described below, 
which was based on one first described by Javadpour and Bush (1972), with the addition of 
the adult kidney as a host site. 
2.6.1 Collection of embryonic kidneys 
Breeding colonies of Swiss, CBA and 129/Sv mice strains were maintained by the 
animal house and timed matings set up. The metanephric rudiments from embryos of 12.5, 
13.5 and 14.5 days p.c. were isolated as described in section 2.1 and stored for up to 2 h on 
ice. 
2.6.2 Operating procedures 
Sexually mature mice were anaesthetised using an intraperitoneal injection of 
Avertin (0.12 ml Avertin made up to 10 ml with PBS and used at a dosage of 0.2 mI /10g 
body weight). For the operations involving the testis, male animals were laid on their backs 
and the lower abdomen swabbed with alcohol. Using sterile instruments an incision was 
made in both the skin and the muscle wall and the animal's left testis exposed, with a small 
tear being made in the capsule. A whole embryonic kidney (14.5 day rudiments were cut in 
half) was sucked into a drawn -out Pasteur pipette, the tip of which was then inserted through 
the tear. The rudiment was expelled at a distance of approximately 5 mm from the tear. In 
the case of the kidney as the host site, male and female mice were laid on their front, the 
area below the ribs swabbed and an incision made parallel to the backbone exposing the 
animal's right kidney. The wound was stitched with surgical suture (Ethicon) and the skin 
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held together with a metal wound clip. For both types of operation the contralateral organ 
was left untreated and severed as the control. The animals were kept warm until fully 
recovered and then monitored for any signs of ill health for the duration of the experiment. 
2.6.3 Recovery of implanted tissue 
The animals were killed by cervical dislocation after a period of between 4 and 26 
weeks with both the operated and control organs being removed and the peritoneal cavity 
examined for metastases. For the kidney, the implanted tissue was usually visible and could 
be removed together with a small area of the adjacent adult organ. The tissue proved more 
difficult to locate in the case of the testis and usually required the whole adult organ to be 
processed into wax and then serially sectioned. The contralateral controls were examined 
for superficial changes and a random selection were fixed and embedded in wax. 
The implanted tissue was processed for in situ mRNA hybridisation, 
immunohistochemistry and TEM as described previously. In almost every case, several 
sections were stained with H & E for routine histological analysis and a selection of these 
was then photographed (see section 2.4.7). 
2.7 Immunohistochemistry 
The indirect immunohistochemistry method was employed, which involves using an 
unlabelled primary antibody that recognises and binds to the tissue antigen. This is detected 
by an enzyme -labelled second antibody raised in another species and a coloured reaction 
product is produced using a substrate of the enzyme. A primary antibody anti -a tubulin, that 
recognised a constituent present in all cells, was used as a positive control and omission of 
the primary antibody served as the negative control. In addition to brush border antibody 
(BB110; Miettinen & Linder, 1976; Ekblom et al., 1980a), a novel monoclonal antibody, 
WT1.27, was used (kindly provided by Veronica van Heyningen and Jonathan Bard). This 
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had been raised in BALB /c mice by immunising them with a sonicated suspension of 
cryopreserved human WT (van Heyningen et al., 1982) and screening was carried out on 
human and mouse embryonic kidney sections. 
The tissue sections were dewaxed by immersion in xylene and rehydrated through 
graded alcohols, before being washed under running tap water. Where necessary, sections 
were treated with Protinase K, before being rinsed in PBS (2 times 5 min). To block non- 
specific binding of the primary antibody, whole serum (diluted 1:10 with PBS) was placed on 
the sections for 10 min. The first antibody was put on at the appropriate dilution (with PBS) 
for 60 min at room temp or overnight at 4 °C. To remove any traces of the first antibody, the 
slides were washed twice with PBS and the serum blocking step repeated, before the 
second antibody (alkaline phosphatase conjugated anti -mouse for WT1.27 and anti -rabbit for 
BB110, both used at a concentration of 1:200 in PBS) was put on for 60 min at room 
temperature. After 2 further PBS washes, the slides were flooded with 0.1 M Tris -HCI (pH 
9.5) for 5 min. The substrate was prepared using the Vector Black kit II as directed by the 
manufacturers, with endogenous alkaline phosphatase activity being blocked by adding 
levamisole (2 mM) to the substrate solution. Sections were immersed in the substrate for up 
to 20 min and for more intense staining allowed to develop in the dark. The reaction was 
stopped in running water and the sections counter stained with 0.01% Malachite green, 
before being air dried, mounted in DPX and photographed using a Zeiss Universal 
microscope. 
2.8 List of suppliers 
Agar Scientific Araldite CY212 
Amersham 35S -UTP 
BCL CsCI 
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BDH Chemicals Ammonium acetate K2HPO4 
Boric acid Isopropanol 
Butan -1 -ol NaCI 
Chloroform NaOH 
DPX Paraffin wax 
Formaldehyde PFA 
Formamide Potassium acetate 
Glucose Propylene oxide 
Glycerol SDS 
Harris's haematoxylin Sucrose 
HCI Urany! acetate 
KH2PO4 Xylene 
Boehringer Mannheim DTT 
RNaseA 
Protinase K Tris 
Restriction enzymes 
Dupont Aquasol 
Difco Bacto -tryptone 
Bacto -yeast extract 
Gibco Ultra pure phenol 
Kodak D19 
Kodaf ix 
Ilford K5 gel emulsion 
Oxkem Osmium tetroxide 
Oxoid PBS 
SAPU Sheep serum 
Sigma Acetic anhydride 
Lysosyme 
Ampicillan Methyl green 
Anti -a- tubulin NaHCO3/Na2CO3 
BSA Orange G 
DEPC Pancreatin 








DNase I T3 polymerase 
pbluescriptKS+ T7 polymerase 
Eosin 
Glutaraldehyde 




THE EXPRESSION OF WT1 DURING MOUSE EMBRYOGENESIS 
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3.1 Introduction 
The expression pattern of the WT1 gene during human embryonic development has 
been studied using both northern blot analysis and in situ mRNA hybridisation (Pritchard - 
Jones, 1992; Pritchard -Jones et aL, 1990). This gene, as described in chapter 1, is strongly 
expressed in the differentiating stem cells of the kidney, in the mesonephros, mesothelium, 
spleen and developing gonads, all tissues that undergo a mesenchyme -to- epithelium 
transition during their development. This pattern, together with the association of WT with 
abnormalities of the urogenital system, suggests that WT1 mutations might have pleiotropic 
effects on both renal and genital development (van Heyningen et aL, 1990). 
There are, however, several problems intrinsic to using human embryonic material: it 
is hard to obtain tissues from early and late gestational stages, to get enough samples of 
tissue of a particular age to be representative and to ensure that such material as can be 
collected is sufficiently fresh for there to have been no significant post -mortem changes. 
Moreover, for obvious ethical and practical reasons, it is impossible to use human material 
experimentally. These difficulties, which have limited the study of the role of WT1 in 
development, are all surmountable with mouse embryonic material as fresh tissues can be 
obtained at any stage and, in addition, some mouse organ rudiments such as the kidney will, 
from their earliest stage, develop well in culture (for review, see Saxen, 1987). Furthermore, 
such evidence as we have, points to much of early development being similar in the two 
species. 
The recent isolation of the mouse homologue of WT1 has allowed this system to be 
utilised, and northern analysis has shown that there are high levels of the gene in the 
developing kidney and the adult spleen and low levels in the adult heart, lung, gonad and 
thymus, with the general level of kidney expression peaking at birth (Buckler et aL, 1991). A 
limited in situ mRNA hybridisation study has investigated the expression of WT1 in the 
mouse genital system and found positive labelling in the non -germ cell components of both 
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the testis and the ovary and in the uterine wall or myometrium (Pelletier et al., 1991a). This 
study also mentions briefly that the mesonephros and the mesothelial lining of the coelomic 
cavity express the gene. 
In the hope that a detailed investigation of WT1 expression would illuminate its 
function more clearly, a thorough in situ mRNA hybridisation study of the developing mouse 
has been undertaken to identify the temporal and spatial distribution of the gene from its 
earliest transcription and the results are presented in this chapter. 
302 Results 
The data presented here detail the sites of WT1 expression during mouse 
postimplantation embryogenesis from day 8 up until just before birth on day 19. The 
developmental stages (according to Theiler, 1989) are given in brackets and the tissues 
using plates and (1990; 1992). Table 3.1 summarises the 
tissues where WT1 was present as assayed by in situ mRNA hybridisation, using the anti - 
sense riboprobe described in chapter 2. The sense probe was used routinely as a negative 
control, with no specific signal being observed in any of the sections examined (e.g. Figure 
3.4a). The metanephric kidney is mentioned briefly, but will be discussed in greater detail in 
chapter 4 in conjunction with the in vitro results. 
3.2.1 The 8 day embryo (Theiler stages 12 and 13) 
This stage of development is distinguished by the initiation of somitogenesis (1 -12 
pairs of somites) and by neural -fold elevation, apposition and fusion (i.e. neurulation) which 
begins in the occipital and cervical regions. Transverse serial sections of 12 embryos were 
examined in 4 separate experiments, but no expression of WT1 was seen in either the 


















































































































































































mesoderm, that give rise to the coelomic cavity and the tissues within it and in particular the 
urogenital system, are present in the 8 day embryo. As these tissues express WT1 later in 
development, the negative results at this stage suggest that the gene is turned on at some 
time after this mesoderm has formed. 
3.2.2 The 9 day embryo (stages 14 and 15) 
The formation of the otic vesicle and closure of the anterior neuropore are the most 
characteristic features of the 9 day embryo, which has between 13 and 29 pairs of somites. 
Towards the end of this period, the forelimb buds become apparent at the level of the 8th - 
12th somite. The first evidence of WT1 transcription was observed in the early 9 day embryo 
(13 pairs of somites), with there being a small patch of expression restricted to the lateral 
lining of the intraembryonic coelomic cavity at the same level as the heart (Figure 3.1a). 
Within 12 h (20 -25 pairs of somites), labelling was more extensive and could be seen over 
the mesothelium, a specialised epithelium bounding the coelomic cavity and the organs 
within it. Expression was particularly strong over the parietal (outer) layer, but could also be 
observed in the visceral layer surrounding the heart and gut. Positive signal was also 
present over the early mesonephros and genital ridge (Figure 3.1b,c), whereas the nephric 
duct was negative (Figure 3.1c). Two unexplained areas of expression were the small 
bilateral wedges of mesenchyme located laterally to the dorsal boundary of the coelomic 
cavity (Figure 3.1b). 
3.2.3 The 10 day embryo (stages 16 and 17) 
This stage of embryogenesis (30 -39 pairs of somites) is marked by the formation of 
the hindlimb buds, which appear as distinct bulges at the level of the 23rd -28th somite. The 
extent of WT1 expression became better defined as the internal organs formed: the 
mesothelial coverings of the heart, early lung -buds, gut and liver showed high levels of 
positive signal, together with the parietal layer lining the coelomic cavity itself (Figure 3.2a,b). 
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Figure 3.1. Early expression of WT1 in the developing mouse embryo. In situ mRNA 
hybridisation to transverse sections using the computer enhanced technique, with labelled 
regions shown in black. a) WT1 was first expressed in the mesenchyme (arrows) lateral to 
the coelomic cavity (C) of an early 9 day embryo (bar: 100 µm). b) In the late 9 day embryo, 
the lining of the coelomic cavity showed positive labelling, with maximal expression at the 
lateral edge (arrows). WT1 was also expressed in the urogenital ridge (Ur) that includes the 
early mesonephros (bar: 200 pm). c) High power micrograph of (b) showing that only the 
early mesonephric tubule and genital ridge were labelled, with the nephric duct (arrows) 










Figure 3.2. Expression of WT1 in the mesonephros. a) Parasagittal section of a 10.5 day 
embryo (b, corresponding dark -field that reveals silver grains, marking the binding sites of 
the anti -sense probe). The mesonephros (Ms), the mesothelial coverings of the 
intracoelomic organs including the heart (H), the mesenchyme ventral to the spinal cord 
(Vm) and the cloaca (arrow) all expressed the gene. The rostral -to- caudal orientation (R,C) 
is given (bar: 400 µm). c) High power micrograph of an adjacent section to (a). The genital 
ridge (Gr), mesonephric mesenchyme and the glomerular pole of the mesonephric tubule 
(arrows) expressed the gene (bar: 100 gm). d) A transverse section through a mesonephric 
tubule illustrating the restriction of WT1 label to the glomerular pole (arrows). The 
mesonephric duct (Md) did not express the gene (bar: 50 gm). 
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An area of undifferentiated mesenchyme ventral to the spinal cord also expressed the gene 
(Figure 3.2a,b) and positive signal was seen overlying mesenchyme that may represent the 
point where the mesonephric duct would later join the cloaca (arrow; Figure 3.2a,b). There 
was heavy labelling over the mesonephros (Figure 3.2a,b), with the tubules showing the 
characteristic pattern of expression previously described for the human embryo (Pritchard - 
Jones, 1992). The mesonephric tubules, particularly the rostral ones, are well- formed at this 
stage (Smith & Mackay, 1991) and, while the majority of the tubule did not express the gene, 
the pole associated with the glomerulus was heavily labelled (Figure 3.2c,d). The genital 
ridge at this stage was observed as a thickening of the coelomic epithelium adjacent to the 
mesonephros and this region expressed the gene at a high level (Figure 3.2c,d), with the 
mesonephric duct being unlabelled (Figure 3.2d). In a late example of an embryo of this 
stage, a low level of expression was observed in the metanephros. It is worth noting that 
WT1 expression has been observed in the mesothelium of a 28 day human embryo 
(Pritchard- Jones, 1992), which corresponds to day 10 of mouse development. 
3.2.4 The 11 day embryo (stages 18 and 19) 
During the 11th day of gestation (40 ->45 pairs of somites), the lens vesicle closes 
and becomes detached from the surface ectoderm and can be used as a criterion for 
recognising this stage of development. In the 11 day embryo, the pattern of WT1 
expression was maintained in all the tissues described for the previous day, with there being 
enhanced expression in the genital ridge and in the metanephric mesenchyme. In 
transverse sections, weak expression was apparent in a narrow linear domain of cells, 
running along the central region of the mouse spinal cord, at the boundary of the mantle and 
ependymal layers (Figure 3.3a,ó). The longitudinal extent of this domain was, however, 
difficult to define, because the level of labelling was so low. 
59 
Figure 3.3. Expression of WT1 in the spinal cord (b,d,f,h and j, are the corresponding dark - 
fields). a) Transverse section of a 11 day embryo, with patches of expression in the central 
region of the spinal cord (bar: 150 µm). c) Transverse section of a 12 day. Expression was 
in the same domain, which was at the border of the ependymal (e) and mantle (m) layer. 
The outer marginal layer (M) was unlabelled (bar: 200 gm). e) Sagittal section of an embryo 
from the same litter as (c), demonstrating the extent of the domain of expression (bar: 150 
gm). g) Transverse section of a 13 day embryo. The domain of expression had moved 
ventrally towards the floor plate (bar: 300 p.m). i) Transverse section of a 15 day embryo. 







3.2.5 The 12 day embryo (stage 20) 
This stage of development can be identified by the early stage of differentiation of 
the distal part of the limbs. In the forelimb, the handplate is seen to have an angular contour 
and the digital interzones demarcate the location of the fingers. In older embryos (stage 21) 
these interzones are more marked, and indentations are present between the tips of the 
fingers. At all stages, the footplate is markedly less advanced than the handplate, so that by 
stage 21, the footplate achieves the same level of differentiation obtained by the handplate 
at stage 20. The pattern of WT1 expression in mice of this age was much as in the 11 day 
embryos studied. The mesonephros, which continued to express the gene, was regressing 
at the rostral end, with the most caudal tubules being highly convoluted. The genital ridge, 
which thickens considerably as the gonads form, showed very strong expression (Figure 
3.4b,c) an observation confirming that of Pelletier et al. (1991a). Careful examination of the 
sections, revealed a slight variation in the level of signal overlying the gonads at this stage 
and may correspond to the morphological distinction of sexual differentiation that is first 
possible at this point in development. In contrast, both sets of genital ducts (mesonephric 
and paramesonephric ducts) were clearly negative (Figure 3.4b,c). Expression of the gene 
was again apparent in the small domain within the spinal cord, but the signal was more 
pronounced than it had been a day earlier (Figure 3.3c,d) and was uniform along the length 
of the cord (Figure 3.3e,f). 
3.2.6 The 13 day embryo (stage 21) 
A characteristic feature of the 13 day embryo is the pronounced degree of 
indentation of the handplate. As before, there was strong expression of WT1 over the 
mesothelial coverings of the major organs, with there being no suggestion of any decline in 
the level of signal. In the genital ridges, sexual differentiation was evident in the forming 
gonads: in both sexes, WT1 expression was restricted to the developing sex cords and the 
overlying mesothelium (Figure 3.4d -f). No evidence of positive signal was observed in either 
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Figure 3.4. Expression of WT1 in the gonads and genital ducts. a) Low power micrograph 
of a sagittal section of the 12 day genital ridge (arrows) hybridised with the sense probe, that 
was used routinely as the negative control and showed no specific labelling. The 
mesonephros (Ms) and metanephros (Mt) are also indicated (bar: 250 µm). b) High power 
of a transverse section through an embryo from the same litter as (a) demonstrating that the 
genital ridge (arrows) and mesonephros (Ms) were labelled, but that the genital ducts (Md, 
Pd) were not (c, dark -field; bar: 100 µm). d) By day 13 of development, WT1 expression 
had become restricted to the epithelial component of the gonad (e, dark- field; bar: 200 µm). 
f) Same section at higher power, showing that the expression seemed to be limited to the 
sex cords (arrows) and overlying mesothelium (hollow arrows; bar: 50 gm). g) In the 15 day 
testis, positive signal was evident in the seminiferous cords (arrows) and the mesothelium 
(bar: 100 µm). i) The mesonephric (Md) and paramesonephric (Pd) ducts did not express 
the gene at any stage of their development, as illustrated by a 13 day embryo (bar: 150 gm). 
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the intervening loose mesenchyme (Figure 3.4d -f) or the genital ducts (Figure 3.4í,j). It was 
not possible in this study to determine unambiguously whether the germ cells expressed 
WT1, but this has been examined (Pritchard- Jones, 1992) in the We mouse mutant that 
lacks germ cells, but has otherwise normal gonads. In male We homozygotes, WT1 
expression was observed to be identical to that of AMH, a marker for Sertoli cells 
(Munsterberg & Lovell- Badge, 1991). Although this does not exclude WT1 expression by 
the germ -cell component of the seminiferous tubules, it does indicate that any expression is 
at a relatively low level. 
One area where expression was present for the first time was a region of condensed 
mesoderm which represented cells that were differentiating into the striated musculature of 
the body -wall (Figure 3.5). WT1 transcription was transient in this domain, because 12 h 
later positive signal was no longer observed in the mesoderm of the body -wall, but was 
instead present in the zones that would later form the inter -thoracic muscles and 
furthermore, both areas were negative by day 15 of development. 
Expression in the spinal cord extended along its length, but was more diffuse than it 
had been a day earlier and was clearly within the ventral region of the mantle layer. At this 
time, the morphology of the spinal cord was changing: the ependymal layer had narrowed 
and, in the ventral part, the mantle layer had expanded to form the ventral horn region 
(Figure 3.4g,h). A similar pattern has been observed in the spinal cord of an human embryo 
corresponding to this stage of mouse development (49 days; Pritchard -Jones, 1992). 
3.2.7 The 15 day embryo (stage 23) 
The embryo at this stage can be distinguished by the digits of the limbs, that are 
clearly divergent and will not become parallel until day 17. The mesothelial coverings of the 
organs in both the pericardial and peritoneal cavities continued to express WT1 (Figure 3.6). 
Although the spleen primordium can be identified by day 13 of mouse development, it was 
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Figure 3.5. Expression of WT1 in the developing musculature of the body wall. a) A line of 
cells (arrows) underlying the ectoderm showed positive labelling (b, dark -field; bar: 100 µm). 
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Figure 3.6. Expression of WT1 in the 15 day embryo (b &d, dark -fields). a) Transverse 
section through the pericardial cavity showing that the mesothelial coverings of the lungs (L) 
and atria (A) and ventricles (V) of the heart were positively labelled. Red blood cells within 
the heart reflect light and are not actually labelled (arrow; bar: 500 pm). c) Transverse 
section through the lower peritoneum. The mesothelial coverings of the spleen (S), 
pancreas (P), bladder (B) and mesorchium (arrows) expressed WT1 as did the metanephroi 
(Mt) and the testes (T; bar: 1 mm). 
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first distinguished in this study in the 15 day embryo. The mesothelium of the spleen 
expressed a high level of WT1, but no signal above the background level was observed in 
the rest of the organ (Figure 3.6c,d). Another tissue that was first identified at this stage of 
development and that expressed WT1 was the mesorchium, the mesothelial- derived 
mesentery from which the testis was suspended (Figure 3.6c,d). 
The domain of strongly expressing cells in the spinal cord was by this stage clearly 
located within the ventral horn region (Figure 3.i,j), and still extended caudally from the 
rostral extremity of the spinal cord to a region distal to the hindlimbs. Expression was 
particularly pronounced in the region of the hindlimbs, but no increase in the level of signal 
was detected in the corresponding area for the forelimbs. In addition, a small area of 
expression was observed in the brain of the embryo (Figure 3.7) and this was restricted to 
the diverticulum of the ependymal layer of the 4th ventricle, close to the rostral section of the 
medulla oblongata. 
Perhaps the most surprising observation made in embryos of this age, however, was 
that the only three organs where gene expression had been turned off were the 
mesonephros, that had almost completely regressed, the non -glomerular components of the 
metanephric nephrons, that originated from the strongly expressing renal vesicles, and the 
condensed domain of body -wall mesoderm that had differentiated into muscle. 
3.2.8 The 19 day embryo (stage 27) 
The length of gestation for the mouse is approximately 19 days and, in the light of 
the work showing that the level of WT1 in the kidney reaches a peak at birth (Buckler et aL, 
1991), an embryo of this age was examined. Here, WT1 expression was substantially 
reduced with clear evidence of transcription being limited to the kidney where it continues 
into adulthood (the gonads and spinal cord were not examined). It was difficult to 
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a 
Figure 3.7. Transverse section through the brain of a 15 day embryo at the level of the 4th 
ventricle. a) A low power micrograph of the whole section. Note that the orientation is such 
that the top of the picture is ventral. Abbreviations; Cp, choroid plexus associated with roof 
of 4th ventricle, D, diencephalon (thalamus), L, lateral ventricle, N, neopallial cortex (future 
cerebral cortex), P, pineal recess of 3rd ventricle and Po, basal plate of pons (bar: 1 mm). 
b) Same section at higher power showing that only the roof of the 4th ventricle expressed 
WT1 (bar: 50 µm). 
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determine whether the mesothelial coverings of the internal organs still expressed the gene, 
but if they did it was at a very low level. 
3.3 Conclusions 
In this chapter a systematic study of the expression of the WT predisposition gene, 
WT1, in the developing mouse using in situ mRNA hybridisation has been reported. It 
confirms published observations on the human fetus (Pritchard -Jones et aL, 1990), with the 
gene being expressed in essentially an identical pattern in the developing renal system, 
gonads and the mesothelial tissues of the coelomic cavity of the two species. For the 
mouse, however, it has been possible to examine much earlier tissue than has hitherto been 
feasible for the human embryo. Here, the temporal and spatial extent of WT1 will be 
considered, with the implications of this work being discussed in the final chapter. 
WT1 transcripts were observed in two distinct sets of tissues that do not seem to be 
related in any obvious way. The first, as has previously been reported (Pritchard -Jones et 
al., 1990; Pelletier et al., 1991a), includes those associated with the mesenchyme -to- 
epithelium transformation within the body cavity, such as metanephric mesenchyme which 
becomes nephrogenic epithelium, the mesothelial cells that line the peritoneal, pleural and 
pericardial cavities and tissues (i.e. the lung, heart, liver, gut, spleen and other abdominal 
organs) and the epithelial cells of the gonads which are of mesodermal origin. The second 
set is a disparate collection of tissues that do not undergo such a transformation and include 
a line of cells within the spinal cord, a small domain of the 4th ventricle of the brain and the 
cells that will go on to form the striated musculature of the body -wall. 
A feature common to most tissues expressing WT1, is that they are a subset of the 
mesoderm. Again, the rule is not universal because the gene is clearly expressed within the 
brain and in a domain of the spinal cord, both of which derive from ectoderm. The 
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expression of WT1 in the spinal cord was first seen in the 11 day embryo, which is when the 
lateral motor columns are being formed, and this location is marked by alkaline phosphatase 
(AP) activity (Kwong & Tam, 1984). It is interesting that the domain of WT1 expression lies 
inside the region of enzyme activity at this time and that the ventral movement of the WT1 
expression pattern over the period 13 -15 days is roughly mirrored by the pattern of AP 
activity. The significance of these results cannot, however, be understood until the fate of 
these two domains is known. 
Given, nevertheless, that most tissues where WT1 transcripts are present are 
examples of mesenchymal differentiation, there are two other noteworthy features about its 
expression. The first is that the gene is turned on after early organogenesis has started and 
the second, is that it may never be fully turned off, even after the organs seem to have 
formed. WT1 expression is first seen at about 9 day of mouse development in lateral 
boundary of the coelomic cavity. At this time, lateral mesoderm is well- established, 13 or so 
pairs of somites can be seen, the heart is forming, a gut is developing and the coelomic 
cavity, with its epithelial lining, has been present for at least 24 h. That WT1 is turned on 
only after these organs have been initiated, argues that its role is limited to the development 
of secondary features of the tissues (i.e. mesothelial differentiation). At the other end of the 
temporal spectrum, WT1 transcripts are present well after the tissues seem to have formed 
and the mesothelium differentiated, as the 15 day data shows. Indeed, in new -born and 
adult gonads (Pelletier et al., 1991a) and in the epithelial podocytes of the renal corpuscle, 
WT1 is still expressed at levels sufficient for detection using the technique of in situ mRNA 
hybridisation. 
If we compare the results obtained in the present study, with those reported 
previously for the mouse by Buckler and co- workers (1991), several discrepancies emerge. 
They reported weak WT1 expression in the adult heart, lung and thymus using northern 
analysis: in contrast, this study has shown that expression was restricted to the embryonic 
pericardium and pleura, with no evidence of positive signal being found in the 15 day 
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thymus. In the first two cases their observations may be accounted for by the mesothelial 
expression, but there seems to be no explanation for the thymus results. In addition, 
although the expression patterns in the developing mouse and human are very similar, there 
does seem to be a difference between the two species in the level of WT1 in the spleen. In 
a 70 day human fetus, a high level of positive signal was seen in the mesothelial covering of 
the spleen and a slightly reduced leve! observed in the parenchyma of the organ (Pritchard - 
Jones et al., 1990). In the mouse, however, WT1 expression was limited to the 
mesothelium. 
In conclusion, the results presented here have confirmed the importance of WT1 in 
tissues undergoing a mesenchyme -to- epithelium transition and have described its 
expression in several tissues that do not fit into this category thus raising more questions 
about its function during development. Further insight into the role played by this gene might 
be obtained from studying the expression of WT1 in the in vitro kidney culture system and in 
the following chapter such a study is described. 
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CHAPTER 4 
THE EXPRESSION OF WT/ IN THE METANEPHRIC KIDNEY 
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4.1 Introduction 
The previous chapter examined the expression pattern of the WT1 gene in the 
developing mouse embryo, but the metanephric kidney was only mentioned briefly and will 
be considered in more detail here. In situ mRNA hybridisation studies have already been 
carried out for the human embryonic kidney (Pritchard -Jones et aL, 1990) and to a very 
limited extent for the mouse (Pelletier et aL, 1991a) and these show that the gene is 
expressed in both species in a specific pattern during nephrogenesis: it is produced at a low 
level in the undifferentiated stem cells of the outer cortex and at a higher level in the renal 
vesicle where it eventually becomes restricted to the podocyte cells of the visceral layer of 
the renal corpuscle. 
One of the great advantages of the mouse is that its metanephric kidney will develop 
in culture to much the same extent that it would have done in vivo. The expression pattern 
of the WT1 gene has yet to be examined in this system and the need for such a study is 
apparent when we consider the amount of experimental work that has been carried out using 
it and the wealth of knowledge generated (see chapter 1, for details). Moreover, the in vitro 
system lends itself to experimental manipulation and, as discussed previously, its use has 
facilitated the study of the mechanisms underlying nephrogenesis. 
The results presented in this chapter couple a detailed study of the expression of 
WT1 in the developing kidney of the mouse embryo itself (from day 11 until day 19) with that 
of the metanephric rudiment in culture using in situ mRNA hybridisation. In order to examine 
the involvement of WT1 in induction, the key event underpinning organogenesis of the 
metanephros, the in vitro transfilter culture system was used. In addition, the pattern of 
WT1 expression in vitro has been used to assay the effects of two molecules, LIF and 
cytochalasin B, that have previously been shown to disrupt nephrogenesis (Bard & Ross, 
1991; Bard, 1990a). By studying WT1 transcription in rudiments cultured under these 
experimental conditions, it has been possible to determine more clearly the point in 
development at which inhibition occurred. 
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4.2 Results 
4.2.1 The pattern of WT1 expression in vivo 
The formation of the mouse metanephric kidney begins very early on day 11 of 
gestation when the ureteric bud invades the domain of condensed cells that constitutes the 
metanephric mesenchyme (refer to Figure 1.2 in chapter 1, for details). The results from the 
in situ mRNA hybridisation experiments reported in chapter 3 had indicated that, in embryos 
of this developmental stage when induction has probably not yet occurred (see section 
4.2.2), there was a low level of WT1 expression over the entire metanephric mesenchyme 
(Figure 4.1). In the 12 day kidney, where induction has taken place and the ureteric bud 
undergone several bifurcations, the cap of condensed mesenchyme surrounding the 
ampullae expressed the gene at a high level (Figure 4.2a,b). In some examples, the whole 
of the mesenchyme seemed to be labelled (Figure 4.2a,b), but in other cases only the cells 
immediately adjacent to the bud expressed the gene. An additional observation that held 
true throughout kidney development was the absence of positive signal over the ureteric bud 
and its branches. 
By day 13 of development, the initial stages of nephron formation could be observed 
(for details, see Figure 1.2). The undifferentiated stem cells at the periphery of the kidney 
expressed WT1 and a specific pattern was observed in the nephrogenic epithelium (Figure 
4.2c). There was uniform positive signal over the whole renal vesicle and this then became 
localised to the cells of the presumptive Bowman's capsule as first the comma- and then the 
S- shaped body formed (Figure 4.3a -c). Careful examination of the tissue at this stage, 
showed that the level of positive signal was substantially higher in the differentiating nephron 
than in the stem cells of the outer cortex (Figure 4.2c). After a further 24 h, the basic 
histoarchitecture of the organ was evident (Figure 4.2d). The stem cells in the cortex of the 
14 day kidney continued to express WT1, but at a level that was considerably lower than 
that observed in Bowman's capsule of the developing nephron (Figure 4.2d,e). It is 
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Figure 4.1. Expression pattern of WT1 in the mouse metanephros before induction. In situ 
mRNA hybridisation to a transverse section of an early 11 day embryo using the computer - 
enhanced technique, with positive signal demonstrated in red. Both the right and left 
kidneys are shown, with each ureteric bud (U) surrounded by a cap of metanephric 
mesenchyme (Mm; bar: 100 µm). 
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Figure 4.2. Localisation of WT1 mRNA in the developing metanephros. a) In the 12 day 
embryo, positive signal was restricted to the metanephric mesenchyme (M) that had 
segregated around the ureteric bud (U). The mesonephric duct (Md) did not express the 
gene (b, dark- field; bar: 150 gm). c) A day later, both the undifferentiated stem cells of the 
outer cortex (hollow arrows) and the developing nephrons (arrows) expressed WT1 (bar: 100 
µm). d) A section of a 14 day kidney, with labelling evident in both the cortex (hollow 
arrows) and Bowman's capsule of the forming nephron (arrows; e, corresponding dark- field; 
bar: 100 gm). f) The 16 day kidney showed a similar pattern of expression (bar: 200 p.m). 
g) In the 19 day kidney, positive signal was only just visible in the cortex (hollow arrows), but 
was still clearly observed in the renal corpuscle (bar: 150 p.m). i) A section of an adult 




Figure 4.3. A series of sections from 13 -16 day embryonic kidneys illustrating the expression 
pattern of WT1 during nephrogenesis (all bars: 50 pm). a) Renal vesicles (arrows), that 
always form on the medullary side of the ureteric bud (U), were uniformly labelled. b) In the 
comma -shaped body (left), WT1 expression was confined to the epithelium of the future 
Bowman's capsule (arrow). The aggregate on the right may have developed further to the 
S- shaped body and demonstrates that positive signal was still restricted to the cells of the 
presumptive Bowman's capsule (arrow). c) A S- shaped body that had elongated and 
convoluted, showing that the gene was localised by this stage to the visceral layer of 
Bowman's capsule (arrows). d) A nephron that seems to be fully mature (curved arrows), 
illustrating that WT1 mRNA was confined to the podocyte cells (arrows). 
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important to note, that after the renal vesicle stage, labelling became restricted to the cells of 
the future renal corpuscle and was never observed in any other section of the nephron. 
Kidneys from 15, 16 and 17 day embryos were also examined and in these the 
temporal and spatial gradient of nephron formation was clearly demonstrated. Within a 
single section, the complete spectrum of development could be observed; from the 
undifferentiated stem cells of the outer cortex, through the increasingly more complex renal 
aggregates to the seemingly mature nephrons in the medulla. In such material, the 
relationship between nephron formation and WT1 expression was evident (Figure 4.2f). The 
stem cells continued to express the gene, although it was difficult to determine whether 
these cells still formed a continuous layer by this stage. The most central nephrons may 
have completed their development, because sections of the distal and proximal tubules 
could be seen lying adjacent to the renal corpuscle and in these cases the gene was 
restricted to the podocyte cells of the visceral layer of Bowman's capsule (Figure 4.3d). 
In the 19 day kidney, the level of WT1 mRNA was only just discernible in the outer 
cortex, although the podocytes of the renal corpuscle continued to express the gene (Figure 
4.2g,h). The adult kidney was also examined, because northern blot analysis had shown 
that the gene was expressed at a low level in this tissue (Buckler et al., 1991). The only 
evidence of positive signal found in the present study was restricted to the podocytes (Figure 
4.2i). 
If we consider the results from the in vivo study, several key observations emerge. 
First, it is clear that the pattern of WT1 expression in the mouse is very similar to that 
described previously in the human (Pritchard -Jones et aL, 1990). The single ambiguity lies 
in the status of the uninduced metanephric mesenchyme, where observations based on 
human fetal tissue, whose fixation is often delayed, had led to the conclusion that the level of 
expression was not significantly above background (Pritchard -Jones et aL, 1990). The 
question of whether WT1 is expressed before induction in the mouse is examined further in 
the next section. Second, the level of WT1 mRNA increases significantly after induction and 
then becomes expressed at a higher level still in the forming nephron, indicating that this 
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gene is transcribed at three different levels during the development of the kidney. Third, as 
the nephron matures, WT1 expression becomes restricted to the visceral epithelial layer of 
the renal corpuscle where it is maintained into adulthood. Finally, the fact that the gene is 
still transcribed at 19 days of development, even at a low level, in cells at the periphery of 
the kidney suggests that in the mouse, nephrogenesis continues into the neonatal period, 
albeit at a reduced rate. 
4.2.2 The relationship between WT1 transcription and induction 
The results from the in vivo analysis imply, but do not prove, that WT1 is present 
before the metanephric mesenchyme is induced. In order to clarify this situation, the 
expression pattern of this gene was studied in the transfilter system, where the effect of 
induction on the metanephric mesenchyme could be analysed directly. 
This in vitro system of kidney culture has already been described in some detail 
(chapters 1 and 2), but it is worth considering the experimental design again briefly. 
Uninduced metanephric mesenchymes were isolated from early 11 day embryos and the 
ureteric buds removed. A proportion of the mesenchymes were fixed at this point, to enable 
the level of WT1 expression in the initial uninduced tissue to be determined. The rest were 
then either cultured alone or with an heterologous inducer, in this case the embryonic spinal 
cord, attached to the opposite side of a porous filter. The length of time that the rudiments 
were cultured for was carefully determined to allow both the initial response to induction to 
be measured (24 h) and the long -term effects of the interaction between the mesenchyme 
and the inducer to be examined (96 h). 
The results presented here describe the material from two independent transfilter 
experiments that were divided to enable 3 separate in situ mRNA hybridisation experiments 
to be carried out, with the results being summarised in Table 4.1. They show that WT1 was 
expressed at a low level prior to induction (Figure 4.4a), but while two of the experiments 
were unequivocal, the third indicated that the gene was not expressed at this point in 
development. In all three experiments, the level of positive signal increased significantly 
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Table 4.1. Summary of the results from the transfilter experiments. 
1st experiment 2nd experiment 3rd experiment 
Oh + + 
24 h: no inducer - + + 
24 h: inducer + ++ ++ 
96 h: no inducer - - - 
96 h: inducer ++ + ++ + ++ 
no expression above background 
+, + +, + ++ level of positive signal 
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Figure 4.4. Expression of WT1 in the in vitro transfilter culture system. Note that all the 
sections were photographed at the same magnification (bar: 30 µm). a) In the metanephric 
mesenchyme removed prior to induction, a low level of WT1 expression was observed. b) In 
mesenchyme cultured for 24 h without an inducer, a low level of positive signal comparable 
to that shown in (a) was seen. c) After 24 h in culture with an inducer, the level of WT1 
expression had increased. d) Mesenchyme cultured without an inducer for 96 h, showed 
poor survival and little if any evidence of WT1 expression. e) After 96 h in culture with an 
inducer, an high level of positive signal was observed, with certain areas showing a greater 
density of silver grains than others. 
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after exposure of the mesenchyme to the inducer for 24 h (Figure 4.4c). In contrast to the 
uniform labelling of the mesenchyme seen after 24 h of culture with an inducer, the 
experiments carried out over 96 h demonstrated an increase in WT1 expression that was 
restricted to the areas of mesenchyme that had aggregated and were undergoing the 
transition to epithelial cells (Figure 4.4e). Finally, although the initial level of mRNA seemed 
to be maintained after 24 h in culture without an inducer (Figure 4.4b), this was not the case 
following 96 h under the same conditions (Figure 4.4d), where the tissue survived very 
poorly and the level of positive signal was negligible. 
Two main points emerge from this data. First, in the absence of inducer, the initial 
low level of WT1 transcription declines and the tissue degrades, proving that the 
mesenchyme was uninduced when it was isolated. It is therefore clear that WT1 is 
expressed in uninduced mesenchyme, but its further production is contingent on induction 
taking place. Second, the data from the experiments where the mesenchyme was 
recombined with the inducer, shows that the effect of induction is to stimulate WT1 
transcription throughout the tissue, but that this production later becomes restricted to the 
forming nephrons. 
4.2.3 The expression of WT1 in the in vitro whole -organ system 
4.2.3.1 Culture in routine medium 
The pattern of WT1 expression in metanephric rudiments cultured in routine medium 
was studied over the course of a 6 day period, with the tissue being examined daily. For 
these experiments, the kidneys were dissected from late 11 day embryos and in contrast to 
the transfilter experiments, the mesenchyrne and ureteric bud components were left intact. 
The changes that occurred in routine culture were useful in two respects; they enabled the 
details of expression to be clarified and they served as a control for the experiments 
described in the following sections. 
After 24 h in culture the ureteric bud had undergone several bifurcations, with each 
tip being surrounded by a cap of condensed mesenchyme (Figure 4.5a). In the material that 
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Figure 4.5. Expression of WT1 in the whole -organ in vitro system (b,c,f,h, dark -fields). a) A 
section of a metanephric rudiment cultured for 24 h. The ureteric bud (curved arrows) had 
bifurcated several times, while the condensed mesenchyme surrounding each tip expressed 
WT1 (arrows; bar: 150 pm). c) After 72 h, the ureteric bud had branched many times and 
was associated with extensive areas of condensed mesenchyme (arrows). Several 
aggregates undergoing the mesenchyme -to- epithelium transition (hollow arrows) could be 
seen and these expressed the gene at a higher level than the condensed mesenchyme (bar: 
150 µm). e) In a rudiment cultured for 96 h, the pattern described in (c) was more striking 
(bar: 100 µm). g) By 144 h, in addition to areas of condensed mesenchyme (arrows), there 
was evidence that WT1 had become restricted in the more mature nephrons to Bowman's 










had been cultured for 72 h there was evidence of aggregates having formed that have been 
shown in previous studies (Ekblom et al., 1980a; 1981a) to be undergoing the transition to 
nephrogenic epithelium (Figure 4.5c). This pattern became more pronounced in the 
rudiments cultured for longer periods, so that by 96 h the ureteric bud had branched many 
times and was associated with extensive areas of condensed mesenchyme (Figure 4.5e). In 
addition, a number of nephrons were observed and these have been demonstrated by this 
stage to have developed many of the features characteristic of this specialised epithelium 
( Ekblom et al., 1980a; 1981a). The data from the in situ mRNA hybridisation experiments 
showed that the cap of condensed mesenchyme surrounding the ampullae of the collecting 
system expressed WT1 at a level that increased substantially as the cells underwent the 
transformation to epithelium (Figure 4.5a -h). It was difficult to distinguish in all cases, 
because of the poor morphological detail preserved after the hybridisation treatment, but in a 
couple of rudiments cultured for 144 h, positive signal was seen to be restricted to the inner 
layer of Bowman's capsule (Figure 4.5g,h). 
From these experiments it is clear that the expression of WT1 in vitro is the same as 
that observed in vivo. It is also worth noting that these rudiments are avascular and as the 
pattern of WT1 expression in the renal corpuscle is not altered significantly from the in vivo 
results, confirms that this structure will develop to a great extent in the absence of 
endothelial cells (Bernstein et al., 1981). 
4.2.3.2 The effect of LIF 
One of the main advantages of studying the development of the metanephric kidney 
in vitro, is that experimental manipulation can be carried out in a controlled environment. It 
is relatively simple to add a defined substance to the culture medium and then observe the 
resulting changes. Here, such a study was carried out using LIF and the rudiments 
subsequently examined for their pattern of WT1 expression. This served two purposes; it 
investigated the use of WT1 as an assay for kidney development and in doing so enabled 
the effect of LIF on the formation of the nephron to be more clearly defined. 
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LIF, inhibits embryonic -stem (ES) cell differentiation in culture (Smith et aL, 1988; 
Williams et aL, 1988) and has been shown to affect the development of leukaemic, 
osteogenic and neuronal cells in vitro (Abe et aL, 1986; Moreau et aL, 1988; Yamamori et 
al., 1989), suggesting that it may have a role in the control of a variety of pluripotent 
mammalian cells. In a recent study, metanephric rudiments cultured in LIF were examined 
and it was found that this glycoprotein had little effect on growth and may have stimulated 
the bifurcation process of the ureteric bud, leading to an increase in the number of collecting 
ducts (Bard & Ross, 1991). They did report a much more pronounced effect on the 
mesenchyme, however, with LIF used at 4 times the concentration needed to inhibit ES -cell 
differentiation (4xLIF) reversibly blocking the effect of induction on the mesenchyme. 
Although the mesenchyme condensed around the ampullae, the number of nephrons formed 
over a 6 day period was reduced by at least 75 %. The fact that the few nephrons that did 
form were grouped around the base of the ureteric bud, led to the suggestion that these 
originated from mesenchyme that had already been induced at the time of dissection from 
the embryo. In addition, an unusually high number of aggregates that expressed laminin 
around their basal surface were found and indicate that LIF could block nephrogenesis at a 
second point. 
In the present study, embryonic kidneys were cultured for 6 days in routine medium 
(this tissue acted as a control, see previous section for details), 4 x LIF and 8 x LIF. In 
rudiments cultured in 4 x LIF (Figure 4.6c,d), the condensed mesenchyme surrounding the 
collecting system expressed WT1 at a level comparable to that observed in the control 
tissue (Figure 4.6a,b). There were also fewer epithelial aggregates expressing a high level 
of WT1 and these tended to be grouped around the basal area of the ureteric bud (Figure 
4.6c,d). Finally, there was some evidence of aggregates that expressed WT1 at an 
intermediate level (Figure 4.6c,d). The results from the rudiments cultured in 8 x LIF were 
similar to those described for the 4 x LIF, but a more extreme effect on the expression 
pattern of WT1 was observed, so that very little evidence of epithelialisation was seen 
(Figure 4.6e,f). 
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Figure 4.6. The effect of LIF on the expression pattern of WT1 in vitro (b,d,f, dark -fields; all 
bars: 200 µm). a) A control rudiment cultured in routine medium, shows that many nephrons 
had formed and these expressed a high level of WT1 (arrows). c) A section of a rudiment 
cultured in 4 x LIF. In comparison to the control (a), there were fewer areas where a high 
level of positive signal was observed (arrows). An intermediate level of signal was seen in 
several areas of condensed cells (hollow arrows). e) There was little evidence of the 







These results show that LIF initially blocks nephrogenesis at a point downstream of 
induction, because not only does the mesenchyme condense around the tips of the 
branching ureteric, but it also expresses WT1 at a level that is indistinguishable from similar 
areas of the control tissue. The observation of aggregates that express the gene at an 
intermediate level, confirms the suggestion that LIF blocks this process at a second point 
(Bard & Ross, 1991) and demonstrates that this is almost certainly at a stage of nephron 
formation after the renal aggregate has undergone the transformation to epithelium. 
4.2.3.3 The effect of cytochalasin B 
In addition to LIF, experiments were carried out in which rudiments were cultured in 
medium containing a low concentration of cytochalasin B (0.2 µg /ml), that is known to 
disrupt microfilament integrity and inhibit filament assembly. Used at such a low level, this 
drug was sufficient to weaken the cytoskeleton of the metanephric rudiment cells, but was 
not enough to affect either cell growth or division of the ureteric bud. In earlier experiments 
it had been reported that, although the mesenchyme in such rudiments formed the initial 
aggregates, these did not go on to become nephrogenic epithelium in the majority of cases 
(Bard, 1990a). 
The results from the in situ mRNA hybridisation experiments undertaken here, 
demonstrated that in rudiments cultured in cytochalasin B the areas of condensed 
mesenchyme surrounding the tips of the branched collecting system expressed WT1 at a 
comparable level to the control tissue, but that there were fewer epithelial aggregates 
(Figure 4.7). This suggests that cytochalasin B inhibits nephrogenesis at a point 





Figure 4.7. The effect of cytochalasin B on the expression pattern of WT1 in culture (b,d, 
dark -fields). a) A control rudiment cultured for 6 days, demonstrating that the developing 
nephron (arrows) expressed the gene at a higher level than the condensed mesenchyme 
surrounding the branches of the collecting system (bar: 200 µm). c) A section of a rudiment 
cultured for 6 days in medium that contained 0.2 µg /ml of cytochalasin B. Development had 
been affected slightly, so that fewer epithelial aggregates had formed (arrows; bar: 250µm). 
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4.3 Conclusions 
In this chapter the pattern of WT1 expression during the formation of the mouse 
metanephric kidney has been examined in detail. If we compare the in vivo results obtained 
here, with those previously published for the human embryo (Pritchard -Jones et aL, 1990), 
then it is clear that the localisation of this gene during nephrogenesis is essentially the same 
between the two mammalian species. One major difference has emerged, however, and 
this concerns the question of whether the metanephric mesenchyme expresses WT1 before 
induction occurs. In contrast to the human fetal kidney, where WT1 expression could not be 
demonstrated in uninduced tissue, it seems that the mouse metanephros does express the 
gene before induction. It cannot, however, be ruled out that this result reflects the 
experimental problems associated with demonstrating such a low level of expression in 
human embryonic material, rather than a real difference between the two species. In both 
species, it is clear that WT1 is upregulated after induction and this result together with the 
increased level of expression in the forming nephron suggests that this gene is transcribed 
at three different levels in developing kidney. Finally, WT1 mRNA was still detectable in the 
adult mouse kidney, albeit at a low level, where it was restricted to the podocyte cells of the 
renal corpuscle. Earlier reports had only examined metanephric tissue from the early 
postnatal period (Pritchard -Jones et al., 1990; Pelletier et al., 1991a), so this observation 
extends the previous understanding of the long -term maintenance of this gene. 
An in vitro study using the whole -organ culture system was also presented in this 
chapter and has shown that the expression pattern of WT1 is the same as that seen in vivo. 
This will be of use when the other genes implicated in WT are isolated, because it will enable 
their temporal and spatial interaction with WT1 to be investigated in a system that can be 
experimentally controlled. The in vitro system has also allowed the effect of manipulating 
the process of nephrogenesis on the pattern of WT1 expression to be investigated and in 
particular has shown that cytochalasin B and LIF exert their effect downstream of induction. 
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The implications of these results together with those obtained in the in vivo study will be not 
be considered here, but will be examined in more detail in the final chapter. 
As the pattern of WT1 expression is very similar in the human and mouse kidneys, it 
is curious that the later does not develop WT. In an attempt to examine this further, a model 
that had previously been proposed to produce these tumours in the mouse (Javadpour & 
Bush, 1972) has been studied and the results are presented in the following chapter. 
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CHAPTER 5 
INVESTIGATING A POSSIBLE MOUSE MODEL OF WILMS' TUMOUR 
94 
5.1 Introduction 
The inherent problems associated with studying human embryonic and tumour material 
mean that an animal model of WT would greatly facilitate the study of both the malignancy itself 
and the role of WT1. Unfortunately, the spontaneous occurrence of nephroblastoma in species 
other than man is extremely rare (Gonzalez- Crossi, 1984; Hard, 1984a,b), with there being only 
one uncorroborated report in the mouse (Guerin et al., 1969). 
Although a genetic model of the disease, the Small -eye (Sey) mutant has been 
described (for details, see chapter 1), the only system put forward that proposes to produce the 
WT phenotype in the mouse has given inconsistent results. This system was first described by 
Javadpour & Bush (1972) who reported that, if embryonic kidney fragments were placed under 
the testis capsule of adult syngeneic mice, large tumours formed that had Wilms' morphology 
and that gave rise to metastases. A re- examination of the model found, however, that the 
transplanted tissue developed normally, albeit at a delayed rate, and could find no evidence of 
metastases (Mount et al., 1974) . 
With the intention of resolving the usefulness of this system, the response of a range of 
mouse strains to the insertion of metanephric rudiments has been investigated and the results 
are presented in this chapter. The adult kidney was used as an additional host site and this 
allowed the dependence of the response on the sex of the host to be analysed for the first time. 
It is of interest, in this context, that the embryonic kidney rudiment has been shown to give rise 
to new functional nephrons when inserted into the cortex of an adult kidney (Woolf et al., 1990). 
The growths obtained in this study were examined both for their basic morphology and for the 
degree of their molecular differentiation using antibodies to developmental markers in 
conjunction with in situ mRNA hybridisation analysis with the mouse WT1 gene. In this chapter 
the results will be described and the implications for this system in the further study of kidney 
disease will be considered. 
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5.2 Results 
5.2.1 The formation of growths 
The strain of mouse used in the original studies, the 129/Sv, is prone to spontaneous 
testicular teratomas (Lyon & Searle, 1989). In order to minimise the effect that this might have 
had on the results, the outbred Swiss mouse strain was used in a preliminary study. The 
results from this initial work did not, however, replicate those of the original study and this led to 
the use of both the 129 /Sv and another inbred strain, the CBA, so enabling the strain 
dependence of the response to be investigated. 
Figures that summarise the numbers of growths obtained and their morphology are 
given in Table 5.1. The overall percentage of growths (64 %) agrees with that of Javadpour & 
Bush (1972), but more were recovered from the kidney (75 %) than the testis (45 %). This 
observation can probably be accounted for by the fact that, while rudiments inserted under the 
kidney capsule could be seen clearly, those within the testis could not. It was not therefore 
possible to ensure that all of the rudiments in the latter case had been successfully transferred. 
In addition, more growths were obtained from the experiments involving 12.5 and 13.5 day 
rudiments than from the 14.5 day tissue, with only 7% of the growths falling into this latter 
group. 
The growths reported by Javadpour & Bush (1972) had obtained a size of greater than 
1 cm in diameter within 4 -6 weeks. In contrast, those obtained in this study, which were initially 
about 0.8 mm in diameter (Figure 5.1a), had reached their maximum of 2 -5 mm after 8 weeks 
(Figure 5.1b). Many of them showed clear signs of vascularisation, but all were easily 
removable from the host tissue and showed no evidence of local invasiveness. 
In order to investigate whether any of the growths gave rise to metastases, the 
carcasses were all examined superficially for evidence of abnormality. In addition, several of 
the mice were given detailed autopsies and in each case their peri- aortic lymph nodes were 
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Figure 5.1. a) A section of a 13.5 day mouse kidney showing part of the bifurcating ureteric bud 
(hollow arrow) with an associated cap of condensed metanephric mesenchyme (M) and a 
comma -shaped stage (solid arrow; bar: 100 µm). b) The kidney from an adult Swiss mouse 
demonstrating the 10 week growth (arrow) that formed following the insertion of a 12.5 day 
rudiment under the capsule (bar: 2 mm). 
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large testicular tumours, but owing to the susceptibility of these mice to such tumours, this was 
considered to be irrelevant to the study. 
The morphology of the growths seemed to be independent of both the time spent in situ 
(for details, refer to section 5.2.2) and of the type of host tissue (see Table 5.1). Major strain 
differences were, however, observed from the analysis of the sectioned material and each of 
these will now be considered in turn. 
5.2.2 Strain -dependent morphology 
5.2.2.1 Swiss mice 
Three distinct morphologies were observed in the 14 growths examined from this strain 
of mouse. The implanted tissue was removed after a period of between 5 -15 weeks, with the 
average length of time being 9 weeks. One growth, removed after 5 weeks, was primarily 
composed of mesenchymal cells that contained little cytoplasm and resembled the blastemal 
component of WT (Figure 5.2a). Three more, which averaged 9.5 weeks, were found to 
comprise of epithelial components that had become cystic (Figure 5.2b): these were analogous 
to those seen in the CBA strain and this morphology is considered in more detail later. The 
remaining 10 growths resembled those of Javadpour & Bush (1972) and had many of the 
histological characteristics of classic triphasic WT. 
This third class of growths contained large areas of mesenchymal cells that included 
randomly distributed epithelial structures and was characterised by a lack of cellular 
organisation (Figure 5.2c -e). The mesenchymal cells of these 'multiphasic' growths had two 
distinct morphologies; those with very little cytoplasm, that resembled blastemal cells and those 
with more cytoplasm that had the appearance of the stromal component of WT (Figure 5.2d). 
An unexpected feature, however, was the observation of many glomeruloid- bodies (Figure 
5.2d). Furthermore, examination of the epithelial components using the TEM, showed the 
presence of tubules with brush borders (Figure 5.2f). These resembled the proximal tubules of 
the adult kidney, with spherical nuclei situated basally and with numerous microvilli forming an 
apical brush border. 
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Figure 5.2. Morphology of the types of growths seen in the Swiss mouse. a) A section of a 5 
week growth that formed when a 12.5 day embryonic kidney was placed under the adult 
kidney (K) capsule. It was composed entirely of mesenchymal cells, with prominent nuclei 
and little cytoplasm, that resembled the blastemal cells of WT (bar: 50 µm). b) A growth 
formed after a 12.5 day rudiment was inserted under the adult kidney capsule and left in 
place for 10 weeks. Large fluid -filled cysts had formed that were lined with epithelial cells 
(bar: 100µm). c) A section through an 8 week growth that formed when a 13.5 day rudiment 
was inserted under the adult kidney (K) capsule (bar: 0.5 mm). d) The same section at 
higher power, illustrating the multiphasic morphology that was characterised by areas of 
blastemal cells (B) and loose mesenchyme (Lm). In addition, there were many glomeruloid- 
bodies (arrows; bar: 100 µm). e) At a higher magnification, a glomeruloid -body (left) and an 
epithelial tubule (right) were evident in the same section (bar: 20 p.m). f) A TEM micrograph 
of a 10 week growth, formed when a 12.5 day rudiment was inserted into the adult kidney 
and showing a tubule with a well- defined brush border, an indicative feature of the proximal 
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Primitive epithelial elements are often observed in WT, but glomeruloid- bodies are less 
common (Payton et al., 1988) and the inclusion of large numbers of such structures in 
themultiphasic growths was the first suggestion that they had undergone a degree of 
differentiation inappropriate for a true model of WT. This was confirmed by the demonstration 
of proximal tubules, which differentiate relatively late in nephrogenesis (Ekblom et aL, 1981a) 
and are rarely seen in WT (Mierau et aL, 1987). 
5.2.2.2 CBA mice 
Of the 23 growths studied in CBA mice (8 -26 weeks; average 17 weeks), one had the 
disorganised morphology characteristic of the Swiss strain (24 weeks, Figure 5.3a), while the 
rest contained large numbers of glomeruloid- bodies associated with, but seemingly 
unconnected to, very large cysts of up to 1 mm in diameter (Figure 5.3b,c). The majority of 
these cysts had a clearly defined epithelial lining and contained acellular material that had 
sometimes become crystalline. A small number of mesenchymal cells could be seen 
sandwiched between the epithelial structures and these resembled the stromal -type cells 
observed in the multiphasic growths. 
Examination of the cystic growths using the TEM showed that the ultrastructure of the 
glomeruloid- bodies was similar to the renal corpuscle of the adult kidney (Figure 5.3d). The 
visceral and parietal layers of Bowman's capsule seemed to be normal and had well- formed 
podocytic processes enveloping the capillaries. This last observation is important, because 
although it was not possible to investigate further, it does indicate that vascularisation of these 
growths had occurred. 
5.2.2.3 129/Sv mice 
The complete range of morphologies was observed in this strain, with a total of 19 
growths remaining in situ for between 9 and 22 weeks (average 13 weeks; Figure 5.4). Of 
these, 3 contained purely blastemal cells (average 12 weeks), 6 had the disorganised 
morphology of the Swiss strain (average 14 weeks) and 10 had the cystic morphology 
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Figure 5.3. Morphology of the types of growths seen in the CBA mouse strain. a) A section of a 
multiphasic growth that formed when a 13.5 day embryonic kidney was inserted underneath the 
kidney capsule and left in situ for 26 weeks. Simple epithelial tubules (arrows) and 
mesenchymal cells resembling the blastemal (B) and stromal (Lm) components of WT were a 
characteristic feature of this type of growth (bar: 30 gm). b) A section of a 15 week growth that 
formed after a 12.5 day rudiment was inserted into the testis (T). This type of growth often 
showed a high degree of organisation, with areas of glomeruloid- bodies (hollow arrows) 
separated from the cystic elements (arrows; bar: 200 µm). c) The same section at higher 
power, illustrating the distended glomeruloid- bodies and fluid -filled cystic elements (bar: 100 
gm). d) A TEM micrograph of a glomeruloid -body from a 7 week growth that formed when a 
13.5 day rudiment was inserted into the adult kidney. The visceral (curved arrows) and parietal 
(arrows) layers were similar to those seen in the Bowman's capsule from a normal adult kidney 
(bar: 5 gm). 
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Figure 5.4. Morphology of the types of growth observed in the 129/Sv mouse. a) A section 
of a 12 week growth, composed entirely of blastemal cells, that formed when a 12.5 day 
embryonic kidney was inserted underneath the kidney capsule of an adult female mouse 
(bar: 30 gm). b) A growth that developed after 10 weeks, when a 13.5 day rudiment was 
transplanted underneath the kidney capsule of an adult female, showing the characteristic 
features of a multiphasic growth (bar: 50 µm). c) In a male mouse, a 13.5 day embryonic 
kidney inserted under the kidney capsule, produced a growth with cystic morphology after 10 




previously described in the CBA strain (average 13 weeks). In this strain of mouse, one third of 
the animals used were female, but there was no obvious difference between the sexes in the 
morphologies of the growths that formed (e.g. Figure 5.4a,b). 
5.2.3 The expression of developmental markers 
In order to clarify the histological observations, immunohistochemistry was carried out 
on a range of growths from the two main morphological categories. A monoclonal antibody that 
recognises the brush border of the rat proximal kidney tubule (BB110; Miettinen & Linder, 1976) 
and cross -reacts with the same segment of the mouse nephron (Ekblom et al., 1980a) was 
used. To complement this epithelial marker of late nephrogenesis, a novel monoclonal antibody 
WT1.27, that had been developed in the MRC Human Genetics Unit, was used during this 
study. This antibody is known to react with a range of both human and mouse mesenchymal 
tissue, including the stem cells and differentiated mesenchyme of the kidney, but fails to 
recognise either induced mesenchyme that is undergoing nephrogenesis or any other epithelial 
tissue (Figure 5.5a). 
In the multiphasic growths, the BB110 antibody reacted with a small number of 
epithelial tubules, while WT1.27 stained the extensive areas of mesenchymal cells seen in this 
category (Figure 5.5b). The cystic growths showed restricted staining with both antibodies, with 
only a subset of the dilated tubules being positive for BB110 and very little evidence of WT1.27 
reactivity (Figure 5.5c). These results confirm the histological analysis, that both types of 
growth had differentiated to a level that was inappropriate for a model of WT. For the cystic 
growths, it was also possible to determine from this data that some of the cysts had formed 
within the proximal tubule of the nephron. 
5.2.4 The expression of WT1 
In addition to immunohistochemistry, the two main morphological categories were 
examined for the expression of the WT predisposition gene, WT1, using in situ mRNA 
hybridisation. In the initial rudiments, the gene would have been expressed in the condensed 
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Figure 5.5. The staining pattern of the monoclonal antibody WT1.27. a) A section of a 17 
week human fetal kidney, illustrating that the stem cells (arrows) and differentiated 
mesenchyme of the medulla (hollow arrows) expressed WT1.27, whereas the epithelium of 
the nephron (curved arrows) did not (bar: 200 µm). b) In a 13 week multiphasic growth, that 
developed following the insertion of a 13.5 day embryonic kidney into the testis of a Swiss 
mouse, extensive staining of the mesenchyme (arrows) was observed (bar: 40 µm). c) A 
section of a cystic growth, formed when a 13.5 day rudiment was placed in the testis of a 
CBA mouse and left in situ for 16 weeks, demonstrating that little staining (arrows) was 
observed in this class of growth (bar: 200 gm). 
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cap of mesenchyme surrounding the collecting system and in the pretubular aggregates, 
becoming confined to the visceral layer of Bowman's capsule as development proceeded (see 
chapter 4, for details). In WT itself, the gene is restricted to the blastemal cells and certain 
epithelial components, that include the glomeruloid -body (Pritchard -Jones & Fleming, 1991). 
The pattern of WT1 expression was thus useful in two respects; to investigate the state of 
differentiation obtained in the growths and as a measure of their true value as a model for WT. 
Examination of the multiphasic growths showed that, although the background was high 
on all the sections, no signal above this level was found in the mesenchymal cells (Figure 5.6a), 
including both those that resembled the blastemal component of WT and those that resembled 
the stromal cells. The epithelial tubules did not express WT1, but the glomeruloid- bodies 
showed a high level of expression, with the signal being confined to the visceral layer of 
Bowman's capsule in the more mature examples (Figure 5.6a). In the cystic growths, positive 
signal was again confined to the glomeruloid- bodies, with no expression above background 
level being observed in the mesenchymal cells or the cystic elements (Figure 5.6b). 
The fact that the blastemal cells did not express WT1 was unexpected in the light of the 
pattern of expression in the initial rudiments and in WT itself and points to the inadequacy of 
this system as a model for the tumour. If we consider the origin of these cells, it can be 
suggested that they were derived from three possible sources; the differentiated mesenchyme 
of the initial rudiment, the stem cells of the outer cortex or the condensed mesenchyme of the 
renal aggregates. In the first instance, the expression pattern of WT1 can be easily explained 
because differentiated mesenchyme does not express this gene. For the other two, the 
situation is different as these cells normally express WT1 and would have had to switch -off the 
transcription of this gene. 
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Figure 5.6. Expression pattern of WT1 using in situ mRNA hybridisation. a) A section of a 10 
week multiphasic growth formed after a 13.5 day embryonic kidney was placed under the 
capsule of the kidney (K) of an adult female 129/Sv mouse (adjacent section to Figure 5.4b). 
Silver grains indicating positive signal were restricted to the glomeruloid- bodies (arrows; bar: 
100 µm). b) In a growth with cystic morphology that formed after 15 weeks in the testis of a 
CBA mouse following the insertion of a 12.5 day rudiment, labelling was again restricted to the 
glomeruloid- bodies (arrows; bar: 100 µm). 
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5.3 Conclusions 
The results presented in this chapter show that the implantation of metanephric 
rudiments underneath the capsule of the testis and the kidney of adult syngeneic mice, leads to 
neither the malignant growth nor the development of metastases described previously 
(Javadpour & Bush, 1972). The rudiments did, however, grow to a certain extent in these 
ectopic sites and underwent varying degrees of differentiation that seemed to depend on the 
strain of mouse used. The potential of this system for modelling Wilms' tumour and its 
usefulness in the study of other aspects of kidney disease will now be considered. 
Of the 3 classes of morphologies observed, the multiphasic growths were the most 
similar to the results from the original study (Javadpour & Bush, 1972) and superficially 
resembled triphasic WT. The demonstration, however, of many glomeruloid- bodies and 
epithelial elements together with results of experiments using developmental markers, leads to 
the conclusion that these growths had undergone a degree of differentiation inappropriate for 
WT. This observation was even more pronounced in the second class of growths, those with 
fluid -filled cysts. In contrast to the large numbers of glomeruloid- bodies and epithelial tubules 
that they contained, these growths had few mesenchymal cells. The third class of growths, 
those that resembled blastemal cells, seems to have arisen from cells that had neither 
differentiated nor divided, a result consistent with their having remained isolated from their 
normal inductive stimulus (i.e. see the transfilter experiments described in chapter 4). The 
expression pattern of WT1 was particularly helpful in investigating how applicable this model 
was to the study of WT and it can be concluded that it is not a reliable method for the 
production of this tumour in the mouse. The strain variability in the morphology of the growths 
obtained is intriguing, but it is difficult to offer any explanation for this effect. 
It is apparent that this study failed to reproduce the observations of Javadpour & Bush 
(1972), but the reasons for this also remain unclear. It has been suggested (Mount et al., 1974) 
that the original tumours arose as a result of contamination of the metanephric rudiment with 
remnants of the genital ridge, which have been shown to produce tumours (Stevens, 1964). 
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Alternatively, the 129/Sv strain used here may have diverged slightly from the original one and 
given the strain variability in the growths produced in this study, this possibility cannot be 
excluded. 
The consistent production of the cystic morphology by the CBA strain of mouse, on the 
other hand, indicates that this model may be of use in the study of polycystic kidney disease 
(PKD), a term that covers a variety of cystic renal disorders (reviewed by Potter, 1972; 
Crawfurd, 1988). Animal models do not yet exist for all the categories of this disease, although 
the C57BL/6J -cpk mouse develops cysts during embryogenesis that resemble those found in 
autosomal recessive PKD ( Preminger et aL, 1982; Mandell et al., 1983). In these mice, small 
dilations of the proximal tubules are seen in embryos and neonates, while the large cysts 
characteristic of the disease seem to be derived from the collecting system. Autosomal 
dominant PKD, the other major inherited form of the disease, also has a murine model 
(Takahashi et aL, 1991), although this has not yet been fully defined. 
In order to investigate the experimental value of the CBA results further, the 
mechanism underlying cyst formation in these mice will need to be investigated. A first step in 
achieving this would be to determine whether ultrafiltration is occurring in this class of growth. 
FITC dextran, that has proved to be a good marker for this process (Woolf et aL, 1990), could 
be injected into the animals systemic system in order to test this hypothesis. Alternatively, 
biochemical analysis could be carried out on the fluid from the cysts and could then be 
compared to values obtained from the blood plasma and the urine. The second type of analysis 
would also enable the segment of the nephron that had become cystic to be examined. 







A key area in the current study of development is the elucidation of the molecular 
controls that underpin cell differentiation and, with the isolation and characterisation of a 
variety of factors involved in committing a stem cell to a specific developmental pathway, we 
are beginning to understand the mechanisms underlying this process. The WT 
predisposition gene, WT1, recently isolated by positional cloning, is of particular interest 
here, because the evidence suggests that it normally plays such a role in kidney 
development, while its mutated form can lead to a tumour. Such a gene should allow the 
relationship between abnormal differentiation and malignancy to be investigated. 
It is within this context that the work presented in thesis should be examined. The 
expression pattern of the mouse homologue of WT1 has been investigated in three 
complimentary systems; the developing embryo, the metanephric kidney both in vivo and in 
vitro and a proposed mouse model of WT. In undertaking such a study, the principal aim 
was to determine the extent of WT1 expression with the intention of clarifying its role in 
normal and aberrant development, with a secondary aim emerging during the course of this 
work which was to examine the use of this gene as an experimental assay of kidney 
development. 
The results underpinning this work come from the human embryo (Pritchard -Jones 
et al., 1990), where it was shown that the renal system, the gonads and the mesothelial 
tissue of the coelomic cavity, all expressed WT1. By examining the mouse, it has been 
possible to extend these observations both temporally, to include the earliest point of 
expression, and spatially, to include several additional tissues. The key results from this 
study have been detailed in each experimental chapter, but here the data will be discussed 
in more depth, with the scope for further experimental work being considered at the end of 
the chapter. 
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6.2 The role of WT1 in non -nephrogenic mouse development 
The limitation of WT1 transcription to a specific set of tissues is in sharp contrast to 
RB1, the paradigm of tumour suppressor genes involved in embryonal malignancies. RB1 is 
expressed ubiquitously during mouse embryogenesis (Bernards et al., 1989), while 
homozygous inactivation of this gene leads to a primary tumour in a specific tissue, the 
retina of the eye (Friend et al., 1986; Fung et al., 1987; Lee et al., 1987). The restricted 
pattern of WT1 expression in the human embryo (Pritchard -Jones et al., 1990) had 
suggested three related and overlapping developmental roles for the gene; in the general 
mesenchyme -to- epithelium transition that is undergone by several of the tissues within the 
coelomic cavity, in the formation of the urogenital system and in nephrogenesis. The results 
obtained in this mouse study need to be considered for each of these in turn: the first two 
examples will be examined here, with nephrogenesis being discussed in a later section. In 
addition, three sites of WT1 expression that do not fit into any of these categories will also 
be considered. 
6.2.1 The mesenchyme -to- epithelium transition 
The transformation of mesenchymal cells to epithelium is relatively rare and has 
received little attention in the literature of development. The one obvious exception is the 
metanephric kidney and this has been studied extensively: here, a reciprocal inductive 
interaction between the ureteric bud and the mesenchyme leads to the latter forming the 
nephrogenic epithelium. In addition to the kidney, WT1 is expressed in the mesothelium, the 
epithelium that lines the coelomic cavity and tissues within it, which derives from lateral plate 
mesoderm. The gene is also transcribed in the spleen and parts of the gonads that are 
thought to arise in turn from the mesothelium. 
There are, however, several well -known tissues undergoing this transition where the 
gene is not expressed during mouse development. These include the corneal endothelium, 
the epithelium at the inner layer of the cornea, which forms from neural- crest -derived 
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fibroblasts (Johnston et al., 1979; Bard & Kratochwil, 1987); the endothelial cells of blood 
vessels, which are, of course, a subset of the epithelia and differentiate from splanchnic- 
mesoderm- derived angioblasts (Balinsky, 1965); the mesonephric duct that forms from 
lateral mesoderm (Poole & Steinberg, 1984) and the somites which go through a 
mesenchyme -to- epithelium transition during their morphogenesis (Duband et al., 1987). In 
addition, the mesothelial lining of the coelomic cavity has differentiated before WT1 
transcription is initiated and the gene clearly has no role in this tissue at this time. 
Furthermore, the adrenal cortex, that does not express WT1 at any stage of its development 
in the mouse embryo, has been suggested to arise from the same origin as the spleen and 
the somatic cells of the gonads ( Gruenwald, 1942), both of which express the gene. 
The role for WT1 in this general class of cell -state transitions therefore seems to be 
more limited than has previously been suggested. The tissues that express the gene may, 
however, have a more subtle connection. In both the mouse and human embryo, WT1 is 
expressed in the mesenchyme underlying parts of the parietal layer of the mesothelium and 
an answer could lie in the nature of this tissue. This point was considered as long ago as 
1942 by Gruenwald, who wrote: 
'It has long been known that the lining of the coelomic cavities differs from other epithelia 
during early periods of development by its close structural and genetic relations to the 
underlying mesenchyme. A persistence of the respective potencies permanently 
distinguishes the coelomic epithelium from other tissues of a similar structure.' 
A similar property of persistence has been attributed to the podocyte cells of the renal 
corpuscle, that are the only part of the nephron to express WT1 after the renal vesicle stage 
and continue to do so long after development of the kidney has ceased. These cells form a 
semi -permeable filtration barrier and do not constitute a true epithelium, losing many of their 
epithelial characteristics as they develop (Garrod & Fleming, 1990). It is possible that WT1 
is involved in the subset of tissues that undergo a mesenchyme -to- epithelium transition, but 
retain certain mesenchymal qualities, although it is clear that until more is understood about 
the nature of this process it will be difficult to determine the exact role of the gene. 
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Nevertheless, as the gene is expressed in the mesothelium, it may be worth 
following the analogy with WT1 expression in both the kidney and in WT and look to see if it 
is also transcribed in mesotheliomas. Second primary tumours are rarely associated with 
WT, but a number of those that have been reported were mesotheliomas (Austin et aL, 
1986). This would not be without precedent, because in RB the most common second 
primary tumour is osteosarcoma (Hawkins et al., 1987) and mutations in the RB1 gene have 
been demonstrated in several of these cases (Friend et al., 1986). 
6.2.2 The development of the urogenital system 
In the case of the urinary and genital systems, there is strong genetic evidence to 
support a functional role for WT1 and this coupled to their common developmental origin and 
the high level of urogenital anomalies associated with WT, has led to the hypothesis that the 
gene has pleiotropic effects on these systems (van Heyningen et al., 1990). Additional 
evidence comes from the analysis of the expression pattern of WT1 in the human fetus, with 
the gene being transcribed during the development of both the kidneys and the gonads 
(Pritchard -Jones et al., 1990). Similar studies have been carried out for the mouse genital 
system (Pelletier et al., 1991a; Pritchard -Jones, 1992) and the kidney (considered in section 
6.3) and these confirm the data from the human. 
The expression pattern of WT1 in the early mouse embryo provides further proof to 
support this hypothesis. Transcription of this gene was observed in the urogenital ridge and 
overlying coelomic epithelium at a stage prior to any evidence of the differentiation of the 
genital component. Our failure, however, to detect WT1 expression in the intermediate 
mesoderm of the 8 day embryo, the tissue that gives rise to the urogenital ridge, suggests 
that this gene is not involved in the earliest stages of urogenital development. 
To digress slightly, the pattern of WT1 expression in the early mouse embryo is 
interesting in the context of the evolutionary development of the urogenital system. The 
formation of the renal system in particular, embodies the idea that 'ontogeny recapitulates 
phylogeny', with the permanent kidneys of the more primitive vertebrate classes being 
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represented during the embryonic development of the amniotes as the transient pronephros 
and the vestigial mesonephros. The expression of WT1 in the early embryo is restricted to 
the coelomic epithelium and the urogenital ridge and it is worth noting that in the lower non - 
amniotic vertebrates, the external glomeruli of the pronephros arise from the coelomic 
epithelium, while in all vertebrates the genital ridges develop from a thickening of this same 
epithelium (Kent, 1987). Furthermore, WT1 has recently been isolated from Xenopus laevis 
(Jill Kent, personal communication), indicating that this gene is conserved between classes 
of vertebrates that are thought to have diverged more than 350 million years ago (McFarland 
et al., 1979). Together these two lines of evidence highlight the fact that this gene might 
have had an important role throughout the evolution of the urogenital system. 
6.2.3 Other sites of WT1 expression 
If we accept that WT1 is involved in the mesenchyme -to- epithelium transition, then a 
second unrelated role is implicated by the demonstration that at least three tissues outwith 
this group express the gene; the cells that are undergoing differentiation into the skeletal 
muscle of the body -wall, a narrow domain within the spinal cord and a small region of the 4th 
ventricle of the brain. The transient expression of WT1 during a specific stage of skeletal 
muscle development is of interest because heterologous elements such as muscle cells are 
observed in some cases of WT (Mierau et al., 1987). 
It is hard to see what part WT1 plays in the differentiation of neural tissue, because 
the specific cells where the gene is expressed do not have a known function. WT1 was first 
transcribed in a small domain of cells at the ependymal- mantle border, before becoming 
restricted to the ventral horn region of the mantle layer from about day 13 of gestation. 
Whilst it is known that the mantle layer goes on to form the grey matter of the spinal cord 
and the ventral horn region contains the cell bodies of the motor neurons, it is difficult to be 
any more definite. It seems unlikely, as has been suggested in the case of the human 
embryo (Pritchard- Jones, 1992), that WT1 is expressed by the motor neurons that innervate 
the limbs, because although there was an elevated level of signal in the region of the 
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hindlimb buds, an increase in the corresponding cervical expansion, that innervates the 
forelimbs, was not observed. 
While little is known about the mechanisms responsible for motor neuron 
differentiation in the spinal cord, it is worth pointing out that other genes involved in 
transcriptional regulation are also expressed within similar domains. Like WT1, but slightly 
ventral to it, the homeobox- containing gene, Hox -8, is expressed in narrow domain on the 
ependymal- mantle border (Duncan Davidson, personal communication), while the engrailed 
gene, En -1, and the paired -box gene, Pax -2, are expressed over more extensive areas 
(Davidson et al., 1988; Nornes et al., 1990). The fact that at least 4 genes with roles in 
development are specifically expressed within a similar region of the spinal cord (they all lie 
within the area of AP activity that marks lateral motor column formation) indicates the need 
to investigate the functional significance of this domain further and suggests that there may 
be a connection among this group of transcription factors. Another point worth making is 
that division of the motor neurons has ceased by day 11 of mouse gestation and they are in 
fact being reduced in number by programmed cell death. This invites comparison with 
another homeobox gene, Hox -7.1, that is expressed in the mouse limb in the regions 
between the digits where cell death is known to occur (Hill et al., 1989). 
A degree of caution should, however, be employed when suggesting a functional 
role for a particular gene based on its pattern of expression alone. In a recent study, gene 
targeting in ES cells was used to disrupt the homeobox containing gene Hox -1.5 and mice 
were then produced that were homozygous for this mutated locus (Chisaki & Capecchi, 
1991). The phenotype of these animals showed that the genetic function of Hox -1.5 is more 
restricted both temporally and spatially (Chisaki & Capecchi, 1991) than had been predicted 
by studies of gene expression using in situ mRNA hybridisation (Gaunt, 1987; 1988). 
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6.3 The role of WT1 in nephrogenesis 
The involvement of WT1 in normal kidney development has been of particular 
interest because mutations in this gene are thought to block the process and can lead to the 
formation of WT. Three separate lines of research indicate that the WT1 gene product, a 
protein with 4 zinc fingers, has an important function in nephrogenesis. First, the WT1 locus 
is sometimes deleted in individuals with the rare WAGR syndrome, a constellation of 
anomalies that includes WT and malformations of the renal system. Second, the expression 
pattern of the gene in the human fetal kidney is consistent with it having a functional role 
during the normal development of this organ. Finally, high- affinity binding sites for the WT1 
protein have been found in the promoters of several genes that are known to be involved in 
nephrogenesis. 
The evidence presented here emphasises this second point: not only is the pattern 
of WT1 expression during the development of the mouse kidney similar in most respects to 
that previously described for the human embryo (Pritchard -Jones et al., 1990), but several 
additional points have also emerged. These allow us to re- evaluate the normal role of this 
gene and in particular its involvement in induction. 
The reciprocal inductive interaction between the ureteric bud and the metanephric 
mesenchyme is the key event underpinning the formation of the kidney. The changes that 
occur in the mesenchyme following induction have been studied extensively and it seems 
evident that this process initiates the production of factors that in turn activate others and 
leads to a cascade that controls the pattern of differentiation (see chapter 1, for details). A 
recent study has shown that the pleuripotency of the stem cells is restricted some time after 
induction, so that a cell contributes to only a single segment of the nephron (Herzlinger et 
al., 1992). Little is known, however, about the mesenchyme before induction takes place, 
although it is recognised as being already committed to becoming nephrogenic tissue 
(Saxen, 1970). 
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The observation that WT1 was expressed in the mouse before induction at a level 
that increased as a direct result of this interaction indicates that the gene plays an important 
part in the process itself. The data is consistent with the idea, which has already been 
proposed (Pritchard -Jones et al., 1990) and will be considered in more detail later, that the 
normal function of WT1 is to regulate the transcription of genes involved in cell proliferation 
and /or differentiation, thus playing a key role in initiating the cascade of nephrogenic 
development. 
We first need to examine the implications of WT1 transcription occurring before 
induction, albeit at a low level. A possible suggestion is that expression of the gene is 
essential for competence. It should, however, be pointed out that expression was first 
detected at a time when the metanephric mesenchyme could already be distinguished from 
the surrounding cells as a discrete group surrounding the ureteric bud, so indicating that 
other factors are involved in assigning a metanephric identity to this particular part of the 
intermediate mesoderm. 
An important question that has not yet been properly addressed is whether all of the 
metanephric mesenchyme is induced in the initial interaction with the ureteric bud. There 
are two lines of evidence that point to this being the case, for the mouse at least. The in 
vitro study demonstrated that the level of WT1 transcription in isolated mesenchyme 
increased uniformly throughout the tissue if it was cultured with an inducer for 24 h. In 
addition, in vivo analysis of 12 and 13 day embryonic kidneys has shown that all of the 
undifferentiated stem cells in the outer cortex of the organ, expressed the gene at a level 
compatible with induction having taken place. Furthermore, the demonstration that LIF 
reversibly blocks nephrogenesis at a point just downstream of induction (see section 6.5) 
confirms the hypothesis that this molecule, or one like it, could provide the restriction that 
would be needed in vivo to allow induced stem cells to enter the nephrogenic pathway of 
differentiation at a controlled rate (Bard & Ross, 1991). 
If we accept the idea that all the mesenchyme is induced during its initial interaction 
with the ureteric bud, then we can answer a second question: is the interstitial mesenchyme 
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of the kidney derived from mesenchyme that is induced? This problem has already been 
examined by Pritchard -Jones & Fleming (1991), who proposed two models based on their 
results from human embryonic and tumour tissue. In the first of these, some of the cells of 
the condensed mesenchyme are excluded from the renal vesicle by the formation of a 
continuous basement membrane and these cells revert back to a mesenchymal phenotype. 
In the second model, the interstitial mesenchyme is suggested to arise directly from the 
uninduced mesenchyme that has not undergone condensation. Our results predict that the 
interstitial mesenchyme is derived from cells that have been induced. This does not, 
however, exclude the second model if it is modified slightly, so that the differentiation 
pathway of the interstitial mesenchyme diverges immediately after, rather than before, 
induction. 
In terms of suggesting a functional role for WT1, the observation that the gene is 
transcribed at three distinct levels in the mouse, is of obvious importance. Having 
considered the first of these, let us now move on to discuss that seen in the induced 
mesenchyme, where WT1 may well initiate the cascade of gene activity that leads to 
nephrogenesis taking place. It seems unlikely that WT1 acts at this stage to repress the 
transcription of genes involved in cell proliferation, because this is the initial reaction of the 
metanephric mesenchyme to induction (reviewed by Saxen, 1987). A more conceivable role 
is the activation of genes involved in cell adhesion, such as syndecan, which are an early 
response to induction and lead to the condensation of the metanephric mesenchyme (Vainio 
et al., 1989). 
The third level of WT1 mRNA was seen in the renal vesicle, which is undergoing the 
mesenchyme -to- epithelium transition. WT1 could be involved at this stage in regulating the 
transcription of a number of genes, including switching off those involved in cell proliferation, 
such as IGF -II, or conversely activating those that specify the epithelial phenotype (see 
chapter 1, for details). It is intriguing that the gene is switched off in the parts of the nephron 
destined not to contribute to the renal corpuscle, but continues to be transcribed into 
adulthood in the podocyte cells, albeit at a reduced level. This observation has already been 
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considered in section 6.2.1, with the suggestion that WT1 is involved in maintaining the 
specialised nature of the podocyte cells. 
Evidence is beginning to accumulate about the downstream targets of WT1 in vitro. 
Work on the sites to which the zinc fingers of WT1 bind shows that the molecule recognises 
the consensus DNA -binding site of the EGR- family of proteins (Rauscher et al., 1990). Such 
high- affinity binding sites have been identified upstream of IGF -11 (Drummond et al., 1991; 
1992), Pax -2 (Dressler et al., 1992) and the NGF- receptor gene (Hannu Sariola, personal 
communication) and may well be present elsewhere. There are, however, two factors that 
distinguish WT1 from the EGR family: it contains an extra zinc finger, with as yet unknown 
binding properties, and the most abundant of the four alternative splice variants contains an 
additional 3 amino acids inserted between the 3rd and 4th fingers, which leads to altered 
binding specificity (Bickmore et al., 1992). It remains an open question as to whether or not 
alternative -splice forms of the protein regulate the downstream expression of different sets 
of genes, although this seems likely with the demonstration that they recognise different 
binding sites (Rauscher et al., 1990; Bickmore et al., 1992). 
In conclusion, our examination of the role of WT1 in normal kidney development, in 
the light of the data from the mouse, suggests that each of the three levels of transcription 
may have a different functional role during the course of nephrogenesis. It is of interest in 
this context, that the Drosophila gap gene Kruppel can act as either an activator or a 
repressor depending on its concentration (Sauer & Jackie, 1991). 
6.4 The role of WT1 in tumorigenesis 
It is thought that WT arises from the aberrant differentiation of abnormally persistent 
nephrogenic stem cells. We have seen in the previous section, that based on its expression 
pattern in the human embryo and its predicted role as a transcription factor, the WT1 gene 
product has been proposed as being involved in committing these stem cells to the 
nephrogenic pathway, . We can therefore consider the mechanism(s) by which mutation of 
the WT1 gene leads to malignancy in the context of its expression and proposed roles in 
normal kidney development. The proportion of tumours that are associated with WT1 
mutations has been estimated by Southern blot analysis and association with WAGR to be 
between 5 -10 %, although this is likely to be a substantial underestimate because many 
mutations would not be detected with these assays (van Heyningen & Hastie, 1992). 
Depending on the timing and nature of the mutation, a spectrum of phenotypes could be 
produced, ranging from congenital abnormalities to malignancy. There is evidence from the 
associated congenital abnormalities that a mutated protein has a more severe effect on 
phenotype than if it is absent (Pelletier et al., 1991b,c; Bruening et al., 1992). This, together 
with the implication of the involvement of two further loci and the variable histological profile 
of the tumour itself, makes the task of elucidating the relationship between WT1 mutation 
and tumorigenesis difficult. While the study presented here can say nothing directly about 
the effect of mutation, we can use the ideas discussed in the previous section, and in 
particular the three levels of WT1 expression, to speculate on how WT could arise as a 
result of WT1 aberration. 
Previous investigations have shown that the cells of the metanephric mesenchyme 
will not grow and divide unless they are induced (Grobstein, 1955). It is therefore difficult to 
envisage how WT, which by its very nature involves uncontrolled cell proliferation, could 
arise from cells that remain uninduced. This in turn implies that malignancy is unlikely to be 
a consequence of mutation of the WT1 locus at the pre- induction stage, even though we 
have shown that the gene is normally expressed at a low level in uninduced metanephric 
mesenchyme. It is possible, on the other hand, that mutation or absence of WT1 at this 
point in development could lead to renal agenesis, one of the congenital abnormalities 
associated with the WAGR syndrome (Miller et al., 1964). 
An initial response of the mesenchyme to induction is an increase in cell proliferation 
(Saxen, 1987) and in this study a concurrent increase in the level of WT1 mRNA was 
observed. Following induction, the stem cells begin to enter the nephrogenic pathway of 
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differentiation and WT1 may play a part in committing these cells. If WT1 is the critical 
factor in the switch from proliferation to epithelial differentiation, then its total inactivation 
would presumably lead to a tumour that was either completely blastemal or that had reverted 
to a stromal phenotype. This has proven not to be the case, because a triphasic tumour has 
been shown to be homozygously deleted for the region containing the gene (Lewis et aL, 
1988). It can be concluded that loss of WT1 is either not the pivotal factor in such tumours 
or that there is some means of bypassing it to allow the limited degree of epithelial 
differentiation seen in this example. If, on the other hand, mutation of WT1 leads to an 
altered or even enhanced protein function, then its aberrant expression could lead to the 
differentiation of epithelial components. 
During normal kidney development, a further increase in the level of WT1 mRNA 
was observed in the renal vesicle and we suggested that this could be important in 
regulating the switch to an epithelial phenotype. Mutation or deletion of WT1 at this stage 
could be a primary event in tumours with a triphasic morphology. 
To summarise, we have shown that WT1 is expressed at three distinct levels in the 
developing kidney and suggested that these may indicate different functional roles. This has 
then been used to explain how this gene could be involved in tumorigenesis at a number of 
stages during nephrogenesis. 
6.5 The use of WT1 as an assay of kidney development 
One of the most useful aspects to emerge from this study is that of employing WT1 as 
a marker of differentiation in the in vitro system of kidney culture. This gene has already been 
shown to be a practical marker for tumour differentiation, because there is a close correlation in 
the expression patterns between the malignant tissue and its normal counterpart, with 
transcription being limited in the tumour to the blastemal cells and immature epithelial 
components (Pritchard -Jones & Fleming, 1991). During the present study, WT1 was used as 
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such a marker, to demonstrate that the growths obtained by the method of Javadpour & Bush 
(1972) had undergone an inappropriate degree of differentiation for a model of WT. 
We have extended this idea to show that WT1 can be used in much the same way to 
examine embryonic kidneys that have been experimentally manipulated. From observations 
made on rudiments cultured under routine conditions, WT1 was shown to be a good marker of 
tissue that had been induced and was undergoing the transition to epithelia. It is also the most 
specific marker of podocyte cells that has been described so far and may be of benefit in future 
in vitro studies, because the formation of Bowman's capsule is often used to determine the 
degree of differentiation achieved during an experiment. 
In addition, WT1 was employed as a marker in rudiments that had been cultured in 
medium containing either LIF or cytochalasin B, substances that had previously been shown to 
block nephrogenesis (Bard & Ross, 1991; Bard, 1990a). This served two purposes, it allowed 
the further investigate of these molecules and in doing so illustrated the application of this gene 
in future studies. By examining the expression pattern of WT1, it was possible to determine 
that both molecules acted at a point downstream of induction, but prior to the transition of the 
mesenchymal aggregate to epithelium. Furthermore, the data confirmed the observation by 
Bard & Ross (1991) that LIF blocks nephrogenesis at a second stage, arresting the further 
development of renal aggregates that had undergone epithelialisation. 
6.6 The limitations of using the mouse to study WT1 and Wilms' tumour 
Despite the almost identical patterns of expression of the WT1 gene in the human 
and mouse embryonic kidneys, we cannot escape the fact that the latter do not develop WT. 
It has been suggested that this could reflect differences in the genetic complexity between 
these species: the two loci on the short arm of chromosome 11 in the human are on 
separate chromosomes in the mouse, so that the homologous region of 11p13 is on 
chromosome 2 and that of 11p15 on chromosome 7. Another hypothesis is that the 
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population of target cells is smaller or more short-lived in the mouse (Glaser et al., 1990), 
although the demonstration here, that WT1 is still being transcribed shortly before birth in a 
few cells in the outer cortex of the kidney, suggests that the stem cells are more persistent in 
this species. 
We must therefore consider briefly how appropriate it is to study WT1 expression in 
the mouse. The benefits of using this species have already been laid out in previous 
chapters and coupled to the similarity in the expression patterns between the two species, 
indicate that the mouse is of value in investigating the normal function of this gene. 
It had been hoped that by studying a system that had been proposed to produce WT 
in mice (Javadpour & Bush, 1972), further insight could be gained into the early stages of 
the eponymous tumour. The demonstration that it was neither an accurate or reliable model 
of the malignancy prevented this aim from being pursued further. 
6.7 Future directions 
In conclusion, it seems that the in situ mRNA hybridisation analysis raises more 
questions than it answers and it is clear that those questions which centre around the 
functional roles of WT1 need to be examined by direct experimentation. This can be 
approached in two distinct ways, by culturing mouse kidney rudiments in the presence of 
anti -sense thio -oligonucleotides which will block WT1 expression (e.g. Sariola et al., 1991) 
and by making transgenic mouse with an incapacitated WT1 gene. Together, the results 
should illuminate the role of WT1 in development and may lead to a better understanding of 
the molecular basis of kidney formation. 
In a wider context, the study of the alternative splice forms of WT1 may help to 
clarify the more diverse aspects of the expression pattern described here. In the long -term, 
the isolation and characterisation of the genes from the other loci implicated in the formation 
of WT will be of paramount importance. It seems likely that these will turn out to either 
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regulate WT1, or be its downstream targets and the in vitro system of kidney culture should 
allow the temporal and spatial relationship of these genes to be investigated. The results 
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The complete nucleotide (3,089 bp) and predicted amino acid sequence of the mouse WT1 cDNA. 
The region of the polypeptide spanning the zinc- finger domain is in bold (Buckler et aL, 1991). The 
cDNA used to transcribe the riboprobe employed in this thesis was 2,362 bp in length and started 








D V R D L N A L LP AV S S L G G G G G G C G L P V S 
gacgtgcgggacctgaacgcgctgctgcccgctgtgtcttcgctgggcggcggcggcggcggctgcgggctccctgtgagc 
G A R Q W A P V L D F A P P GA S A Y G S L G G P AP 
ggcgcacggcagtgggcgcccgtgttggacttcgcgcctccgggcgcctcggcttacgggtcgctgggcggtcccgcgcct 
P P A P P P P P P P P H S F I K Q E P S W G G A E P H 
cctcccgctccgccgccgcctccgccgccaccccactccttcatcaaacaggagcccagctggggcggcgccgagccaca 
E E Q C L S A F T L H F S G Q F T G T A G A C R Y G P 
gaggagcagtgcctgagcgccttcaccttgcacttctcgggccagttcaccggtacagccggggcctgtcgctacggaccc 
F G P P P P S Q A S S G Q A R M F P N A P Y LP S C L 
ttcggtcctcccccgcccagccaggcgtcctcgggccaggccaggatgttccccaatgcgccctacctgcccagctgcctg 
E S Q P T I R N Q G Y S TV TF D G A P S Y G H T P S 
gagagccagcctaccatccgcaaccaaggatacagcacggtcactttcgacggggcgcccagctatggccacacgccctcg 
H H A A Q F P N H S F K H E D P M G Q Q G S L G E Q Q 
catcacgcggcgcagttccccaaccattccttcaaacacgaggaccccatgggccagcagggctcgctgggcgagcagcag 
YS V P P P V Y G C H TP T DS C T G S Q A L L L R T 
tactccgtgccacctccggtgtatggctgccacacccctactgacagttgcacaggcagccaggccctgctcctgaggacg 
P Y SS D N L Y Q M T S Q L E C M T W N Q M N L G A T 
ccctacagcagtgacaatttataccaaatgacctcccagcttgaatgcatgacctggaatcagatgaacctaggagctacc 
L K G M A A G S S S S V K W T E G Q S N H G T G Y E S 
ttaaagggaatggctgctgggagctccagctcagtgaaatggácagaagggcagagcaaccacggcacagggtacgagagt 
E N H T AP I L C G A Q Y R I H T H G V F R G I Q D V 
gagaaccacacggcccccatcctctgtggtgcccagtacagaatacacacccacggggtcttccgaggcattcaggatgtg 
RR V S G V AP T L V R S A SE T S E K R P F M C A Y 
cggcgtgtatctggagtggccccaactcttgtccggtcagcatctgaaaccagtgagaaacgtcctttcatgtgtgcatac 
P G C N K R Y F K L S H L Q M H S R K H T G E K P Y Q 
ccaggctgcaataagagatattttaagctgtcccacttacagatgcatagccggaagcacactggtgagaaaccataccag 
C D F K D C E R R F SR S D Q L K R H Q R R H T G V K 
tgtgacttcaaggactgcgagagaaggttttctcgctcagaccagctcaaaagacaccaaaggagacacacaggtgtgaaa 
P F Q C K T C Q R K F SR S D H L K T R T R TH T G E 
ccattccagtgtaaaacttgtcagcgaaagttttcccggtccgaccatctgaagacccacaccaggactcatacaggtaaa 
T S E K P F S C R W H S C Q K K F A R S D E L V R I I I I 
acaagtgaaaagcccttcagctgtcggtggcacagttgtcagaaaaagtttgcgcgctcagacgaattggtccgccatcac 




















cacttggctgt caattaaagt ctattcaaaagga 
149 
Comparison of the predicted amino acid sequences of the mouse and human WT1 polypeptide. 
Vertical bars indicate amino acids that are conserved between the two species and the alternative 
splices are in bold (Buckler et al., 1991). 
mouse MGSDVRDLNALLPAVS S LGGGGGGCGLP VS GARQWAPVLDFAP P GASAYG 50 
111111111111111 II 111111 111111 11111111111111111 
human MGSDVRDLNALLPAVPSL- GGGGGCALPVSGAAQWAPVLDFAPPGASAYG 49 
SLGGPAPPPA-PPPPPPPHSFIKQEPSWGGAEPHEEQCLSAFTLHFSGQF 100 
1111111111 I1111111111111111111111111111111 111111 
SLGGPAPPPAPPPPPPPPHSFIKQEPSWGGAEPHEEQCLSAFTVHFSGQF 100 
TGTAGACRYGPFGPPPPSQASSGQARMFPNAPYLPSCLESQPTIRNQGYS 150 
1111111111111111111111 I 11111111111 11111111 1111111 
TGTAGACRYGPFGPPPP SQAS SGQARMFPNAPYLP SCLESQPAIRNQGYS 150 
TVTFDGAPSYGHTPSHHAAQFPNHSFKHEDPMGQQGSLGEQQYSVPPPVY 200 
111111 111111111111111111111111111111,1111111111111 














IIIIIIIIIIIIIIIIII 11111111111111111111111111 II 
HTRTHTGKTSEKPFSCRWPSCQKKFARSDELVRHHNMHQRNMTKLQLAL 449 
150 
